Form 8-K

8-K — BranchOut Food Inc.

Accession: 0001493152-26-048512

Filed: 2026-10-26

Period: 2026-10-23

CIK: 0001962481

SIC: 2000 (FOOD & KINDRED PRODUCTS)

Item: Entry into a Material Definitive Agreement

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-1.1 (ex1-1.htm)

EX-5.1 (ex5-1.htm)

EX-99.1 (ex99-1.htm)

GRAPHIC (ex5-1_001.jpg)

GRAPHIC (ex99-1_001.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0001962481

2026-10-23

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date

of Report (Date of earliest event reported): October 23, 2026

BRANCHOUT

FOOD INC.

(Exact

name of registrant as specified in its charter)

Nevada

001-41723

87-3980472

(State

or other jurisdiction

(Commission

(I.R.S.

Employer

incorporation)

File

Number)

Identification

Number)

205

SE Davis Avenue, Bend Oregon

97702

(Address

of principal executive offices)

(Zip

Code)

(844)

263-6637

(Registrant’s

telephone number, including area code)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions:

☐

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

Stock, par value $0.001 per share

BOF

Nasdaq

Capital Market

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

1.01. Entry into a Material Definitive Agreement.

October 23, 2026, BranchOut Food Inc., a Nevada corporation, (the “Company”) entered into an underwriting agreement (the

“Underwriting Agreement”) with Lake Street Capital Markets LLC as the representative of the underwriters named therein (the

“Representative” and any such other underwriters, the “Underwriters”), relating to the issuance and sale by the

Company to the Underwriters (the “Offering”) of 2,941,177 shares (the “Shares”) of the Company’s common

stock, par value $0.001 per share (the “Common Stock”), at a price to the public of $1.70 per share, less underwriting discounts

and commissions. Pursuant to the Underwriting Agreement, the Representative was granted an option, for a period of 30 days, to purchase

from the Company up to 441,176 additional shares of Common Stock, at the same price per share, to cover over-allotments, if any.

The

Shares are being sold and issued pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-299400), which was

declared effective by the Securities and Exchange Commission (the “SEC”) on October 16, 2026, the prospectus contained therein,

and a prospectus supplement related to the offering of the Shares dated October 23, 2026 (the “Prospectus Supplement”).

Pursuant

to the Underwriting Agreement, the Company agreed to a 7.0% underwriting discount on the gross proceeds received by the Company for the

Shares, in addition to reimbursement of certain expenses, made customary representations, warranties and covenants concerning the Company,

and also agreed to indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as

amended. In addition, the officers and directors of the Company have agreed not to offer, sell, transfer or otherwise dispose of any

shares of Common Stock, the Company’s common stock, or securities convertible into, or exercisable or exchangeable for, shares

of Common Stock, during the 90-day period following the date of the Underwriting Agreement, and the Company agreed that it will not issue

or announce the issuance or proposed issuance of any shares of Common Stock or common stock equivalents during the same 90-day period,

other than certain exempt issuances.

The

Offering closed on October 26, 2026. The Company received net proceeds from the Offering of approximately $4,600,000 after deducting

the underwriting discounts and commissions, legal fees of the Representative and estimated offering expenses payable by the Company in

connection with the Offering.

described in the Prospectus Supplement, the Company intends to use the net proceeds from the Offering for working capital and general

corporate purposes, including operating expenses and capital expenditures.

The

foregoing description of the Underwriting Agreement is qualified in its entirety by reference to the full text of the Underwriting Agreement,

which has been filed as Exhibit 1.1 to this Current Report on Form 8-K, and incorporated into this Item 1.01 by reference. The legal

opinion of Pachulski Stang Ziehl & Jones LLP with respect to the validity of the Shares is filed as Exhibit 5.1 to this Current Report

on Form 8-K.

This

Current Report on Form 8-K, including the exhibits filed herewith, shall not constitute an offer to sell or the solicitation of an offer

to buy the Shares, nor shall there be any offer, solicitation or sale of the Shares in any state in which such offer, solicitation or

sale would be unlawful prior to registration or qualification under the securities laws of such state.

Item

8.01. Other Events

October 23, 2026, the Company issued a press release announcing the pricing of the Offering, a copy of which is furnished herewith as

Exhibit 99.1 to this Current Report on Form 8-K.

Item

9.01. Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit

1.1

Underwriting Agreement, dated October 23, 2026, between the Company and Lake Street Capital Markets LLC , as Representative of the Underwriters

Exhibit

5.1

Opinion

of Pachulski Stang Ziehl & Jones LLP

Exhibit

23.1

Consent of Pachulski Stang Ziehl & Jones LLP (included in Exhibit 5.1)

Exhibits

99.1

Press Release dated October 23, 2026

Exhibit

104

Cover

Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant

to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf

by the undersigned hereunto duly authorized.

BranchOut

Food Inc.

Date:

October 26, 2026

By:

/s/

Eric Healy

Eric

Healy, Chief Executive Officer

EX-1.1

Filename: ex1-1.htm · Sequence: 2

Exhibit

1.1

EXECUTION COPY

UNDERWRITING

AGREEMENT

and between

BRANCHOUT

FOOD INC.

And

LAKE

STREET CAPITAL MARKETS LLC,

Representative of the Several Underwriters

BRANCHOUT

FOOD INC.

UNDERWRITING

AGREEMENT

October

23, 2026

Lake

Street Capital Markets LLC

As Representative of the several Underwriters named on Schedule 1 hereto

c/o

Lake Street Capital Markets LLC

121

South 8th Street, Suite 1000

Minneapolis, MN 55402

Ladies

and Gentlemen:

The

undersigned, BranchOut Food Inc., a company incorporated under the laws of the State of Nevada (the “Company”), hereby confirms

its agreement (this “Agreement”) with Lake Street Capital Markets LLC, as the representative of the several underwriters

named in Schedule 1 hereto (the “Representative” and such other underwriters being collectively called the “Underwriters”

or, individually, an “Underwriter”) as follows:

Purchase and Sale of Shares.

1.1.

Firm Shares.

1.1.1.

Nature and Purchase of Firm Shares.

(i)

On the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the Company

agrees to issue and sell to the several Underwriters, an aggregate of 2,941,177 shares (the “Firm Shares”) of the Company’s

common stock, par value $0.001 per share (the “Common Stock”).

(ii)

The Underwriters, severally and not jointly, agree to purchase from the Company the number of Firm Shares set forth opposite their respective

names on Schedule 1 hereto and made a part hereof at a purchase price of $1.581 per share (93% of the per Firm Share public offering

price). The Firm Shares are to be offered to the public at the public offering price set forth on Schedule 2-A hereto and on the cover

page of the Prospectus (as defined in Section 2.1.1 hereof).

1.1.2.

Shares Payment and Delivery.

(i)

Delivery and payment for the Firm Shares shall be made at 10:00 a.m., Eastern time, on the first (1st) Business Day following the date

of this Agreement pursuant to Rule 430B(f)(2) under the Securities Act (or the second (2nd) Business Day following the date of this Agreement

if pricing occurs after 4:01 p.m., Eastern time), or at such other time as shall be agreed upon by the Representative and the Company,

at the offices of Sullivan & Worcester LLP, 1251 Avenue of the Americas, New York, New York 10020 (“Representative Counsel”),

or at such other place (or remotely by electronic transmission) as shall be agreed upon by the Representative and the Company. The hour

and date of delivery and payment for the Firm Shares is called the “Closing Date.”

(ii)

Payment for the Firm Shares shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order of the

Company, upon delivery of the certificates (in form and substance satisfactory to the Underwriters) representing the Firm Shares (or

through the facilities of the Depository Trust Company (“DTC”)) for the account of the Underwriters. The Firm Shares

shall be registered in such name or names and in such authorized denominations as the Representative may request in writing at least

one (1) full Business Day prior to the Closing Date. The Company shall not be obligated to sell or deliver the Firm Shares except upon

tender of payment by the Representative for all of the Firm Shares. The term “Business Day” means any day other than

a Saturday, a Sunday or a legal holiday or a day on which banking institutions are authorized or obligated by law to close in New York,

New York.

1.2.

Over-allotment Option.

1.2.1.

Option Shares. For the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Shares,

the Company hereby grants to the Representative an option to purchase up to 441,176 additional shares of Common Stock, representing fifteen

percent (15%) of the Firm Shares sold in the offering, from the Company (the “Over-allotment Option”). Such 441,176

additional shares of Common Stock, the net proceeds of which will be deposited with the Company’s account, are hereinafter referred

to as “Option Shares.” The purchase price to be paid per Option Share shall be equal to the price per Firm Share set

forth in Section 1.1.1 hereof. The Firm Shares and the Option Shares are hereinafter referred to together as the “Public Securities.”

The offering and sale of the Public Securities is hereinafter referred to as the “Offering.”

1.2.2.

Exercise of Option. The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Representative

as to all (at any time) or any part (from time to time) of the Option Shares within 30 days after the date of this Agreement. The Representative

shall not be under any obligation to purchase any Option Shares prior to the exercise of the Over-allotment Option. The Over-allotment

Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must be confirmed in

writing by overnight mail or electronic transmission setting forth the number of Option Shares to be purchased and the date and time

for delivery of and payment for the Option Shares (the “Option Closing Date”), which shall not be later than five (5) full

Business Days after the date of the notice or such other time as shall be agreed upon by the Company and the Representative, at the offices

of Representative Counsel or at such other place (including remotely other electronic transmission) as shall be agreed upon by the Company

and the Representative. If such delivery and payment for the Option Shares does not occur on the Closing Date, the Option Closing Date

will be as set forth in the notice. Upon exercise of the Over-allotment Option with respect to all or any portion of the Option Shares,

subject to the terms and conditions set forth herein, (i) the Company shall become obligated to sell to the Representative the number

of Option Shares specified in such notice and (ii) the Representative shall purchase that portion of the total number of Option Shares

then being purchased as set forth in Schedule 1.

1.2.3.

Payment and Delivery. Payment for the Option Shares shall be made on the Option Closing Date by wire transfer in Federal (same

day) funds, payable to the order of the Company upon delivery to the Representative of certificates (in form and substance satisfactory

to the Underwriters) representing the Option Shares (or through the facilities of DTC) for the account of the Representative. The Option

Shares shall be registered in such name or names and in such authorized denominations as the Representative may request in writing at

least one (1) full Business Day prior to the Option Closing Date. The Company shall not be obligated to sell or deliver the Option Shares

except upon tender of payment by the Representative for applicable Option Shares. The Option Closing Date may be simultaneous with, but

not earlier than, the Closing Date; and in the event that such time and date are simultaneous with the Closing Date, the term “Closing

Date” shall refer to the time and date of delivery of the Firm Shares and Option Shares.

1.3.

[Reserved].

Representations and Warranties of the Company. The Company represents and warrants to the Underwriters as of the Applicable Time

(as defined below), as of the Closing Date and as of the Option Closing Date, if any, as follows:

2.1.

Filing of Registration Statement.

2.1.1.

Pursuant to the Securities Act. The Company has filed with the U.S. Securities and Exchange Commission (the “Commission”)

a registration statement on Form S-3 (File No. 333-299400), including a base prospectus, registering the offer and sale from time to

time, on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”),

of up to $50,000,000 in aggregate offering amount of common stock, preferred stock, warrants and units, including the Public Securities

offered hereby. Such registration statement, at any given time, including amendments thereto, exhibits and schedules thereto, documents

filed as a part thereof or incorporated by reference therein and documents and information otherwise deemed to be a part thereof pursuant

to Rule 430B (the “Rule 430B Information”) of the rules and regulations of the Commission under the Securities Act (the “Securities

Act Regulations”) or otherwise pursuant to the Securities Act Regulations, is referred to herein as the “Registration Statement.”

The Registration Statement was declared effective by the Commission on October 16, 2026. The prospectus included in the Registration

Statement at the time it became effective is herein called the “Base Prospectus.”

Promptly

after the execution and delivery of this Agreement, the Company will prepare and file with the Commission a final prospectus supplement

to the Base Prospectus relating to the Public Securities and the Offering in accordance with Rule 430B and Rule 424(b) of the Securities

Act Regulations. Such final prospectus supplement, together with the Base Prospectus, in the form first filed with the Commission pursuant

to Rule 424(b), and any amendments or supplements thereto, is herein called the “Prospectus.” Any reference herein to the

Base Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to

Item 12 of Form S-3 under the Securities Act as of the date of such prospectus.

“Applicable

Time” means 5:00 p.m., Eastern time, on the date of this Agreement.

“Issuer

Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433 of the Securities Act Regulations

(“Rule 433”), including without limitation any “free writing prospectus” (as defined in Rule 405 of the Securities

Act Regulations) relating to the Public Securities that is (i) required to be filed with the Commission by the Company, (ii) a “road

show that is a written communication” within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission,

or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description of the Public Securities

or of the Offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission

or, if not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g).

“Issuer

General Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is intended for general distribution to prospective

investors (other than a “bona fide electronic road show,” as defined in Rule 433 (the “Bona Fide Electronic Road Show”))

“Issuer

Limited Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.

“Disclosure

Package” means the Base Prospectus, the Prospectus dated October 23, 2026, any Issuer General Use Free Writing Prospectus issued

at or prior to the Applicable Time and the information included on Schedule 2-A hereto, all considered together.

2.1.2.

Pursuant to the Exchange Act. The Common Stock is registered pursuant to Section 12(b) of the Securities Exchange Act of 1934,

as amended (the “Exchange Act”) and the Company has taken no action designed to, or which to its knowledge is likely

to have the effect of, terminating the registration of the Common Stock under the Exchange Act, nor has the Company received any notification

that the Commission is contemplating terminating such registration.

2.2.

Stock Exchange Listing. Except as set forth in the Registration Statement, the Company has not, in the 12 months preceding

the date hereof, received notice from the Nasdaq Capital Market (the “Exchange”) to the effect that the Company is

not in compliance with the listing or maintenance requirements of the Exchange. Except as set forth in the Registration Statement, the

Company is in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer

through DTC or another established clearing corporation and the Company is current in payment of the fees of DTC (or such other established

clearing corporation) in connection with such electronic transfer.

2.3.

No Stop Orders, etc. Neither the Commission nor, to the Company’s knowledge, any state regulatory authority has issued

any order preventing or suspending the use of the Registration Statement or the Prospectus or has instituted or, to the Company’s

knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied with each request (if any)

from the Commission for additional information.

2.4.

Disclosures in Registration Statement.

2.4.1.

Compliance with Securities Act and 10b-5 Representation.

(i)

Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective and at each deemed effective

date with respect to the Underwriters pursuant to Rule 430B(f)(2) of the Securities Act Regulations, complied and will comply in all

material respects with the requirements of the Securities Act and the Securities Act Regulations. Each Prospectus, at the time each was

or will be filed with the Commission, complied and will comply in all material respects with the requirements of the Securities Act and

the Securities Act Regulations. The Prospectus was or will be identical to the electronically transmitted copies thereof filed with the

Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.

(ii)

Neither the Registration Statement nor any amendment thereto, at its effective time, as of the Applicable Time, at the Closing Date or

at any Option Closing Date (if any), contained, contains or will contain an untrue statement of a material fact or omitted, omits or

will omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances

under which they were made, not misleading.

(iii)

The Disclosure Package, as of the Applicable Time, at the Closing Date or at any Option Closing Date (if any), did not, does not and

will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,

in the light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free Writing Prospectus does

not conflict in any material respect with the information contained in the Registration Statement, the Base Prospectus or the Prospectus,

and each such Issuer Limited Use Free Writing Prospectus, as supplemented by and taken together with the Prospectus as of the Applicable

Time, did not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements

therein, in light of the circumstances under which they were made, not misleading; provided, however, that this representation and warranty

shall not apply to statements made or statements omitted in reliance upon and in conformity with written information furnished to the

Company with respect to the Underwriters by the Representative expressly for use in the Registration Statement or the Prospectus or any

amendment thereof or supplement thereto. The parties acknowledge and agree that such information provided by or on behalf of any Underwriter

consists solely of the statements concerning the Underwriters furnished in writing by the Representative expressly for inclusion in the

“Underwriting” section of the Prospectus (the “Underwriters’ Information”).

(iv)

Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time

of any filing with the Commission pursuant to Rule 424(b), at the Closing Date or at any Option Closing Date, included, includes or will

include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the

statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that this representation

and warranty shall not apply to the Underwriters’ Information.

2.4.2.

Disclosure of Agreements. The agreements and documents described in the Registration Statement, the Disclosure Package and the Prospectus

conform in all material respects to the descriptions thereof contained therein and there are no agreements or other documents required

by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the Disclosure Package and the

Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described or filed. Except

as set forth in the Registration Statement, each agreement or other instrument (however characterized or described) to which the Company

is a party or by which it is or may be bound or affected and (i) that is referred to in the Registration Statement, the Disclosure Package

and the Prospectus, or (ii) is material to the Company’s business, has been duly authorized and validly executed by the Company,

is in full force and effect in all material respects, and is enforceable against the Company and, to the Company’s knowledge, the

other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization

or similar laws affecting creditors’ rights generally, (y) as enforceability of any indemnification or contribution provision may

be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms

of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor

may be brought. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, none of such agreements

or instruments has been assigned by the Company, and neither the Company nor, to the Company’s knowledge, any other party is in

default thereunder and, to the Company’s knowledge, no event has occurred that, with the lapse of time or the giving of notice,

or both, would constitute a default thereunder except for such defaults that would not reasonably be expected to result in a Material

Adverse Change (as defined below). To the Company’s knowledge, performance by the Company of the material provisions of such agreements

or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental

agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses (each, a “Governmental

Entity”), including, without limitation, those relating to environmental laws and regulations or taxes, except for such violations

that would not reasonably be expected to result in any change or development that, singularly or in the aggregate, would involve a material

adverse change, in or affecting the condition (financial or otherwise), results of operations, business, assets or prospects of the Company

(a “Material Adverse Change”).

2.4.3.

Prior Securities Transactions. To the extent material or otherwise required to be disclosed therein, no securities of the Company have

been sold by the Company or by or on behalf of, or for the benefit of, any person or persons controlling, controlled by or under common

control with the Company, except as disclosed in the Registration Statement, and the Disclosure Package.

2.4.4.

Regulations. The disclosures in the Registration Statement, the Disclosure Package and the Prospectus concerning the effects of federal,

state, local and all foreign regulation on the Offering and the Company’s business as currently contemplated are correct in all

material respects and no other such regulations are required to be disclosed in the Registration Statement, the Disclosure Package and

the Prospectus which are not so disclosed.

2.4.5.

No Other Distribution of Offering Materials. The Company has not, directly or indirectly, distributed and will not distribute any offering

material in connection with the Offering other than the Disclosure Package, the Prospectus and other materials, if any, permitted under

the Securities Act and consistent with Section 3.2 below.

2.5.

Changes After Dates in Registration Statement.

2.5.1.

No Material Adverse Change. Since the respective dates as of which information is given in the Registration Statement, the Disclosure

Package and the Prospectus, except as otherwise specifically stated therein: (i) there has been no material adverse change in the financial

position or results of operations of the Company, nor to the Company’s knowledge, a Material Adverse Change; and (ii) there have

been no material transactions entered into by the Company not in the ordinary course of business, other than as contemplated pursuant

to this Agreement.

2.5.2.

Recent Securities Transactions, etc. Subsequent to the respective dates as of which information is given in the Registration Statement,

the Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the Registration

Statement, the Disclosure Package and the Prospectus, the Company has not: (i) issued any securities, other than securities issued pursuant

to the Company’s existing equity incentive plans or shares issuable upon the exercise of then outstanding options, warrants and

convertible securities, which in each case were disclosed in the Prospectus, Disclosure Package or the Registration Statement, or incurred

any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other distribution

on or in respect to its capital stock.

2.6.

Independent Accountants. To the knowledge of the Company, M&K CPAS, PLLC (the “Auditor”), whose report is filed with

the Commission as part of the Registration Statement, the Disclosure Package and the Prospectus, is an independent registered public

accounting firm as required by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board.

Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Auditor has not, during the periods

covered by the financial statements included in the Registration Statement, the Disclosure Package and the Prospectus, provided to the

Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.

2.7.

Financial Statements. The financial statements of the Company, including the notes thereto and any supporting schedules, included or

incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus comply in all material respects with

the applicable accounting requirements of the Securities Act, the Exchange Act and the rules and regulations of the Commission thereunder,

as applicable, and fairly present in all material respects the financial position of the Company as of the dates indicated and the results

of operations and cash flows of the Company for the periods specified. Such financial statements have been prepared in conformity with

United States generally accepted accounting principles (“GAAP”) applied on a consistent basis throughout the periods involved,

except as may be expressly stated in the related notes thereto and, in the case of unaudited interim financial statements, subject to

normal year-end audit adjustments and the omission of certain footnotes as permitted by the applicable rules of the Commission. Any supporting

schedules included or incorporated by reference in the Registration Statement, the Disclosure Package or the Prospectus fairly present

in all material respects the information required to be stated therein. The pro forma financial statements and related notes, if any,

included or incorporated by reference in the Registration Statement, the Disclosure Package or the Prospectus have been properly compiled

and prepared in accordance with the applicable requirements of the Securities Act, the Exchange Act and the rules and regulations of

the Commission thereunder, as applicable, and the assumptions used in the preparation thereof are reasonable and the adjustments used

therein are appropriate to give effect to the transactions and circumstances referred to therein. No other historical or pro forma financial

statements or supporting schedules are required to be included or incorporated by reference in the Registration Statement, the Disclosure

Package or the Prospectus under the Securities Act, the Exchange Act or the rules and regulations of the Commission thereunder.

2.8.

Form S-3 Eligibility; Exchange Act Reports; Shelf Capacity. The Company meets the registrant requirements of Form S-3 and the applicable

transaction requirements for the Offering, including General Instruction I.B.6 of Form S-3. The Company has been subject to the requirements

of Section 12 or 15(d) of the Exchange Act and has filed all reports, schedules, forms, statements and other documents required to be

filed by the Company with the Commission pursuant to the Securities Act and the Exchange Act, including pursuant to Sections 13, 14 or

15(d) of the Exchange Act, for at least twelve (12) calendar months immediately preceding the date hereof. All such reports, schedules,

forms, statements and other documents, including the exhibits thereto and documents incorporated by reference therein, are referred to

herein collectively as the “SEC Reports.” The Company has timely filed all SEC Reports required to be filed during the twelve

(12) calendar months and any portion of a month immediately preceding the date hereof. The Company is eligible to offer and sell the

Public Securities pursuant to the Registration Statement and the Base Prospectus. After giving effect to the sale of all of the Firm

Shares and Option Shares offered pursuant to this Agreement, together with all other securities sold by or on behalf of the Company pursuant

to General Instruction I.B.6 of Form S-3 during the twelve-calendar-month period immediately prior to and including the date of this

Agreement, the aggregate market value of such securities will not exceed one-third of the aggregate market value of the voting and non-voting

common equity held by non-affiliates of the Company, calculated in accordance with General Instruction I.B.6 of Form S-3. Sufficient

securities remain registered and unsold under the Registration Statement to cover all of the Firm Shares and Option Shares, and all required

filing fees have been paid or will be paid in accordance with the Securities Act Regulations. The SEC Reports incorporated or deemed

incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, when filed with the Commission, complied

in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and the applicable rules and

regulations of the Commission thereunder, and none of such SEC Reports contained an untrue statement of a material fact or omitted to

state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under

which they were made, not misleading. Any further reports, schedules, forms, statements or other documents filed with the Commission

and incorporated or deemed incorporated by reference in the Registration Statement, the Disclosure Package or the Prospectus through

the Closing Date or any Option Closing Date will comply in all material respects with such requirements and will not contain any such

untrue statement or omission.

2.9.

Authorized Capital; Options, etc. The Company had, at the date or dates indicated in the Registration Statement, the Disclosure Package

and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions stated

in the Registration Statement, the Disclosure Package and the Prospectus, the Company will have on the Closing Date the adjusted stock

capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Disclosure Package and

the Prospectus, on the date of this Agreement, as of the Applicable Time and on the Closing Date and any Option Closing Date, there will

be no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued shares of Common Stock of

the Company or any security convertible or exercisable into shares of Common Stock of the Company, or any contracts or commitments to

issue or sell shares of Common Stock or any such options, warrants, rights or convertible securities.

2.10.

Valid Issuance of Securities, etc.

2.10.1.

Outstanding Securities. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement

have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission

with respect thereto, and are not subject to personal liability by reason of being such holders; and none of such securities were issued

in violation of the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company.

The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained in the Registration

Statement, the Disclosure Package and the Prospectus. The offers and sales of the outstanding shares of Common Stock were at all relevant

times either registered under the Securities Act and the applicable state securities or “blue sky” laws or, based in part

on the representations and warranties of the purchasers of such Shares, exempt from such registration requirements. The description of

the Company’s stock option, stock bonus and other stock plans or arrangements, and the options or other rights granted thereunder,

as described in the Registration Statement, the Disclosure Package and the Prospectus, accurately and fairly present, in all material

respects, the information required to be shown with respect to such stock plans, arrangements and the options and rights granted thereunder.

2.10.2.

Securities Sold Pursuant to this Agreement. The Public Securities have been duly authorized for issuance and sale and, when issued and

paid for in accordance with this Agreement, will be validly issued, fully paid and non-assessable; the holders thereof are not and will

not be subject to personal liability by reason of being such holders; the Public Securities are not and will not be subject to the preemptive

rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required

to be taken for the authorization, issuance and sale of the Public Securities has been duly and validly taken. The Public Securities

conform in all material respects to all statements with respect thereto contained in the Registration Statement, the Disclosure Package

and the Prospectus.

2.11.

Registration Rights of Third Parties. Except as set forth on Schedule 2.10 hereto, or in the Registration Statement, the Disclosure

Package and the Prospectus, no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable

into securities of the Company have the right to require the Company to register any such securities of the Company under the Securities

Act or to include any such securities in a registration statement to be filed by the Company.

2.12.

Validity and Binding Effect of Agreements. This Agreement has been duly and validly authorized by the Company, and, when executed

and delivered, will constitute, the valid and binding agreements of the Company, enforceable against the Company in accordance with their

respective terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting

creditors’ rights generally; (ii) as enforceability of any indemnification or contribution provision may be limited under the federal

and state securities laws; and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be

subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.

2.13.

No Conflicts, etc. The execution, delivery and performance by the Company of this Agreement and all ancillary documents, the consummation

by the Company of the transactions herein and therein contemplated and the compliance by the Company with the terms hereof and thereof

do not and will not, with or without the giving of notice or the lapse of time or both: (i) result in a material breach of, or conflict

in any material respect with any of the terms and provisions of, or constitute a material default under, or result in the creation, modification,

termination or imposition of any material lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms

of any agreement or instrument to which the Company is a party; (ii) result in any violation of the provisions of the Company’s

articles of incorporation (as the same may be amended or restated from time to time, the “Charter”) or the bylaws

of the Company (the “Bylaws”); or (iii) violate any existing applicable law, rule, regulation, judgment, order or

decree of any Governmental Entity as of the date hereof; except in the cases of clause (iii) above, for such breaches, conflicts or defaults

that would not reasonably be expected to result in a Material Adverse Change.

2.14.

No Defaults; Violations; Organization. No material default exists in the due performance and observance of any term, covenant

or condition of any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement

or instrument evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company is a party

or by which the Company may be bound or to which any of the properties or assets of the Company is subject. The Company is not in violation

of any term or provision of its Charter or Bylaws, or corresponding governing documents, as applicable. The Company is not in violation

of any franchise, license, permit, applicable law, rule, regulation, judgment or decree of any Governmental Entity, except for such violations

that would not reasonably be expected to result in a Material Adverse Change.

2.15.

Corporate Power; Licenses; Consents.

2.15.1.

Conduct of Business. Except as described in the Registration Statement, the Disclosure Package and the Prospectus, the Company has all

requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates and permits

(“Permits”) of and from any Governmental Entity that it needs as of the date hereof to conduct its business purpose as described

in the Registration Statement, the Disclosure Package and the Prospectus, except for such Permits the absence of which would not reasonably

be expected to have a Material Adverse Change.

2.15.2.

Transactions Contemplated Herein. The Company has all corporate power and authority to enter into this Agreement and to carry out the

provisions and conditions hereof, and all consents, authorizations, approvals and orders required in connection therewith have been obtained.

No consent, authorization or order of, and no filing with, any court, government agency or other body is required for the valid issuance,

sale and delivery of the Public Securities and the consummation of the transactions and agreements contemplated by this Agreement and

as contemplated by the Registration Statement, the Disclosure Package and the Prospectus, except (i) such consents, approvals, authorizations,

orders, filings, registrations or qualifications that have already been obtained or made and (ii) with respect to applicable federal

and state securities laws and the rules and regulations of the Financial Industry Regulatory Authority, Inc. (“FINRA”).

2.16.

D&O Questionnaires. To the Company’s knowledge, all information contained in the questionnaires (the “Questionnaires”)

completed by each of the Company’s directors and officers prior to the Offering (the “Insiders”) as supplemented by

all information concerning the Company’s directors, officers and principal stockholders as described in the Registration Statement,

the Disclosure Package and the Prospectus, as well as in the Lock-Up Agreements (as defined in Section 2.24 below), provided to the Underwriters,

is true and correct in all material respects and the Company has not become aware of any information which would cause the information

disclosed in the Questionnaires to become materially inaccurate or incorrect in any material respect.

2.17.

Litigation; Governmental Proceedings. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or

governmental proceeding pending or, to the Company’s knowledge, threatened against, or involving the Company or, to the Company’s

knowledge, any executive officer or director, which has not been disclosed in the Registration Statement, the Disclosure Package and

the Prospectus or in connection with the Company’s listing application for the listing of the Public Securities on the Exchange,

which individually or in the aggregate, if determined adversely to the Company would reasonably be expected to have a Material Adverse

Change.

2.18.

Good Standing. The Company has been duly organized and is validly existing as a corporation and is in good standing under the

laws of the State of Nevada as of the date hereof, and is duly qualified to do business and is in good standing in each other jurisdiction

in which its ownership or lease of property or the conduct of business requires such qualification, except where the failure to qualify,

singularly or in the aggregate, would not have or reasonably be expected to result in a Material Adverse Change.

2.19.

Insurance. The Company carries or is entitled to the benefits of insurance, with reputable insurers, in such amounts and covering

such risks which the Company believes are adequate, and all such insurance is in full force and effect. The Company has no reason to

believe that it will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable

coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would

not reasonably be expected to result in a Material Adverse Change.

2.20.

Transactions Affecting Disclosure to FINRA.

2.20.1.

Finder’s Fees. Except as described in the Registration Statement, the Disclosure Package and the Prospectus, there are no claims,

payments, arrangements, agreements or understandings relating to the payment of a finder’s, consulting or origination fee by the

Company or any Insider with respect to the sale of the Public Securities hereunder or any other arrangements, agreements or understandings

of the Company or, to the Company’s knowledge, any of its stockholders that may affect the Underwriters’ compensation, as

determined by FINRA and neither the Company nor, to the Company’s knowledge any Insider has paid any monies or other compensation

or issued any securities to any member of FINRA, or to any affiliate or associate of such a member, regarding this Offering.

2.20.2.

Payments Within Twelve (12) Months. Except as described in the Registration Statement, the Disclosure Package and the Prospectus, the

Company has not made any direct or indirect payments (in cash, securities or otherwise) in connection with the Offering to: (i) any person,

as a finder’s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing

to the Company persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any

direct or indirect affiliation or association with any FINRA member, within the twelve (12) months prior to the date of this Agreement,

other than the payment to the Underwriters as provided hereunder.

2.20.3.

Use of Proceeds. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its

affiliates, except as specifically authorized herein.

2.20.4.

FINRA Affiliation. (i) No officer or director of the Company, and to the knowledge of the Company (ii) no beneficial owner of

5% or more of any class of the Company’s securities and (iii) no beneficial owner of the Company’s unregistered equity securities

which were acquired during the 180-day period immediately preceding the filing of the Registration Statement, is an affiliate or associated

person of a FINRA member participating in the Offering (as determined in accordance with the rules and regulations of FINRA).

2.20.5.

Information. All information provided by the Company in its FINRA questionnaire to Representative Counsel specifically for use

by Representative Counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct

and complete in all material respects.

2.21.

Foreign Corrupt Practices Act. None of the Company nor, to the Company’s knowledge, any director, officer, agent, employee

or affiliate of the Company or any other person acting on behalf of the Company, has, directly or indirectly, given or agreed to give

any money, gift or similar benefit (other than legal price concessions to customers in the ordinary course of business) to any customer,

supplier, employee or agent of a customer or supplier, or official or employee of any Governmental Entity or any political party or candidate

for office (domestic or foreign) or other person who was, is, or may be in a position to help or hinder the business of the Company (or

assist it in connection with any actual or proposed transaction) that (i) might subject the Company to any damage or penalty in any civil,

criminal or governmental litigation or proceeding, (ii) if not given in the past, might have caused a Material Adverse Change or (iii)

if not continued in the future, might adversely affect the assets, business, operations or prospects of the Company. The Company has

taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material

respects with the Foreign Corrupt Practices Act of 1977, as amended.

2.22.

Compliance with OFAC. None of the Company nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate

of the Company or any other person acting on behalf of the Company, is currently subject to any U.S. sanctions administered by the Office

of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”), and the Company will not knowingly, directly

or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available such proceeds to any joint

venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions

administered by OFAC.

2.23.

Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance in all material respects

with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as

amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations

or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the “Money Laundering Laws”);

and no action, suit or proceeding by or before any Governmental Entity involving the Company with respect to the Money Laundering Laws

is pending or, to the best knowledge of the Company, threatened.

2.24.

Officers’ Certificate. Any certificate signed by any duly authorized officer of the Company and delivered to the Representative

or to Representative Counsel shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered

thereby.

2.25.

Lock-Up Agreements. Schedule 3 hereto contains a complete and accurate list of the Company’s officers and directors

that will be subject to a Lock-Up Agreement (collectively, the “Lock-Up Parties”). The Company has caused each of

the Lock-Up Parties to deliver to the Representative an executed Lock-Up Agreement, in the form attached hereto as Exhibit A (the “Lock-Up

Agreement”), prior to the execution of this Agreement.

2.26.

Related Party Transactions. There are no business relationships or related party transactions involving the Company or any other

person required to be described in the Registration Statement, the Disclosure Package and the Prospectus that have not been described

as required.

2.27.

Board of Directors. The Board of Directors of the Company is comprised of the persons disclosed in the Registration Statement,

the Disclosure Package and the Prospectus. The qualifications of the persons serving as board members and the overall composition of

the board comply with the Exchange Act, the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder

(the “Sarbanes-Oxley Act”) applicable to the Company and the listing rules of the Exchange. At least a majority of the persons

serving on the Board of Directors qualify as “independent,” as defined under the listing rules of the Exchange.

2.28.

Sarbanes-Oxley Compliance. The Company is in material compliance with any and all applicable requirements of the Sarbanes-Oxley

Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission

thereunder that are effective as of the date hereof and as of the Closing Date.

2.29.

Accounting Controls. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company

maintains systems of “internal control over financial reporting” (as defined under Rules 13a-15 and 15d-15 under the Exchange

Act Regulations) that comply in all material respects with the requirements of the Exchange Act applicable to the Company and have been

designed by, or under the supervision of, its respective principal executive and principal financial officers, or persons performing

similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial

statements for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide

reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii)

transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability;

(iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded

accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to

any differences. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company is not aware

of any material weaknesses in its internal controls. The Company’s auditors and the Audit Committee of the Board of Directors of

the Company have been advised of: (i) all significant deficiencies and material weaknesses in the design or operation of internal controls

over financial reporting which are known to the Company’s management and that have adversely affected or are reasonably likely

to adversely affect the Company’s ability to record, process, summarize and report financial information; and (ii) any fraud known

to the Company’s management, whether or not material, that involves management or other employees who have a significant role in

the Company’s internal controls over financial reporting.

2.30.

No Investment Company Status. The Company is not and, after giving effect to the Offering and the application of the proceeds

thereof as described in the Registration Statement, the Disclosure Package and the Prospectus, will not be, required to register as an

“investment company,” as defined in the Investment Company Act of 1940, as amended.

2.31.

No Labor Disputes. No labor dispute with the employees of the Company exists or, to the knowledge of the Company, is imminent.

The Company is not aware that any key employee or significant group of employees of the Company plans to terminate employment with the

Company.

2.32.

Intellectual Property Rights. The Company owns or possesses or has valid rights to use all patents, patent applications, trademarks,

service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and

similar rights (“Intellectual Property Rights”) necessary for the conduct of the business of the Company as currently carried

on and as described in the Registration Statement, the Disclosure Package and the Prospectus. To the knowledge of the Company, no action

or use by the Company necessary for the conduct of its business as currently carried on and as described in the Registration Statement

and the Prospectus will involve or give rise to any infringement of, or license or similar fees for, any Intellectual Property Rights

of others (other than license or similar fees described or contemplated in the Registration Statement, the Disclosure Package and the

Prospectus). The Company has not received any notice alleging any such infringement, fee or conflict with asserted Intellectual Property

Rights of others. Except as described in the Registration Statement, the Disclosure Package and the Prospectus or except as would not

reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change (A) to the knowledge of the Company,

there is no infringement, misappropriation or violation by third parties of any of the Intellectual Property Rights owned by the Company;

(B) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the rights

of the Company in or to any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable

basis for any such claim, that would, individually or in the aggregate, together with any other claims referred to in this Section 2.31,

reasonably be expected to result in a Material Adverse Change; (C) the Intellectual Property Rights owned by the Company and, to the

knowledge of the Company, the Intellectual Property Rights licensed to the Company have not been adjudged by a court of competent jurisdiction

invalid or unenforceable, in whole or in part, and there is no pending or, to the Company’s knowledge, threatened action, suit,

proceeding or claim by others challenging the validity or scope of any such Intellectual Property Rights, and the Company is unaware

of any facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other

claims referred to in this Section 2.31, reasonably be expected to result in a Material Adverse Change; (D) there is no pending or, to

the Company’s knowledge, threatened action, suit, proceeding or claim by others that the Company infringes, misappropriates or

otherwise violates any Intellectual Property Rights or other proprietary rights of others, the Company has not received any written notice

of such claim, and the Company is unaware of any other facts which would form a reasonable basis for any such claim that would, individually

or in the aggregate, together with any other claims referred to in this Section 2.31, reasonably be expected to result in a Material

Adverse Change; and (E) to the Company’s knowledge, no employee of the Company is in or has ever been in violation in any material

respect of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement,

non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such

violation relates to such employee’s employment with the Company, or actions undertaken by the employee while employed with the

Company and could reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company’s

knowledge, all material technical information developed by and belonging to the Company which has not been patented has been kept confidential.

The Company is not a party to or bound by any options, licenses or agreements with respect to the Intellectual Property Rights of any

other person or entity that are required to be set forth in the Registration Statement, the Disclosure Package and the Prospectus and

are not described therein. The Registration Statement, the Disclosure Package and the Prospectus contain in all material respects the

same description of the matters set forth in the preceding sentence. None of the technology employed by the Company has been obtained

or is knowingly being used by the Company in material violation of any contractual obligation binding on the Company or, to the Company’s

knowledge, any of their respective officers, directors or employees, or otherwise in material violation of the rights of any persons.

The Company owns or has a valid right to access and use all computer systems, networks, hardware, software, databases, websites, and

equipment used to process, store, maintain and operate data, information, and functions used in connection with the business of the Company

(the “Company IT Systems”). The Company IT Systems are adequate for, and operate and perform in all material respects as

required in connection with, the operation of the business of the Company as currently conducted, except as would not, individually or

in the aggregate, reasonably be expected to have a Material Adverse Change. The Company has implemented commercially reasonable backup,

security and disaster recovery technology consistent in all material respects with applicable regulatory standards and customary industry

practices.

2.33.

Taxes. The Company has filed all material returns (as hereinafter defined) required to be filed with taxing authorities prior

to the date hereof or has duly obtained extensions of time for the filing thereof. The Company has paid all material taxes (as hereinafter

defined) shown as due on such returns that were filed and has paid all material taxes imposed on or assessed against the Company. The

provisions for taxes payable, if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient

for all accrued and unpaid material taxes, whether or not disputed, and for all periods to and including the dates of such consolidated

financial statements. Except as disclosed in writing to the Underwriters, (i) no material issues have been raised (and are currently

pending) by any taxing authority in connection with any of the returns or taxes asserted as due from the Company, and (ii) no waivers

of statutes of limitation with respect to the returns or collection of taxes have been given by or requested from the Company. There

are no tax liens against the assets, properties or business of the Company other than liens for taxes not yet delinquent or being contested

in good faith by appropriate proceedings and for which reserves in accordance with GAAP have been established in the Company’s

books and records. The term “material taxes” means all federal, state, local, foreign and other net income, gross income,

gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment,

excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments or charges

of any kind whatever, together with any interest and any penalties, additions to tax or additional amounts with respect thereto, other

than those taxes, the failure of which to have paid, would not result in a Material Adverse Change. The term “material returns”

means all returns, declarations, reports, statements and other documents required to be filed in respect to taxes, other than those returns,

the failure of which to have filed, would not result in a Material Adverse Change.

2.34.

ERISA Compliance. The Company and any “employee benefit plan” (as defined under the Employee Retirement Income Security

Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, “ERISA”)) established

or maintained by the Company or its “ERISA Affiliates” (as defined below) are in compliance in all material respects with

ERISA. “ERISA Affiliate” means, with respect to the Company, any member of any group of organizations described in

Sections 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder

(the “Code”) of which the Company is a member. No “reportable event” (as defined under ERISA) has occurred

or is reasonably expected to occur with respect to any “employee benefit plan” established or maintained by the Company or

any of its ERISA Affiliates. No “employee benefit plan” established or maintained by the Company or any of its ERISA Affiliates,

if such “employee benefit plan” were terminated, would have any “amount of unfunded benefit liabilities” (as

defined under ERISA). Neither the Company nor any of its ERISA Affiliates has incurred or reasonably expects to incur any material liability

under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any “employee benefit plan” or (ii) Sections

412, 4971, 4975 or 4980B of the Code. Each “employee benefit plan” established or maintained by the Company or any of its

ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and, to the knowledge of the Company,

nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification.

2.35.

Compliance with Laws. The Company: (A) is and at all times has been in compliance with all statutes, rules, or regulations applicable

to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale,

offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company (“Applicable Laws”),

except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change (any such noncompliance

being referred to as “nonmaterial noncompliance” for the purposes of this Section 2.34); (B) has not received any warning

letter, untitled letter or other correspondence or notice from any other Governmental Entity alleging or asserting material noncompliance

with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments

thereto required by any such Applicable Laws (“Authorizations”); (C) possesses all material Authorizations and such

material Authorizations are valid and in full force and effect and are not in material violation of any term of any such Authorizations;

(D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action

from any Governmental Entity or third party alleging that any product operation or activity is in violation of any Applicable Laws or

Authorizations and has no knowledge that any such Governmental Entity or third party is considering any such claim, litigation, arbitration,

action, suit, investigation or proceeding that if brought would result in a Material Adverse Change; (E) has not received notice that

any Governmental Entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations and has

no knowledge that any such Governmental Entity is considering such action; (F) has filed, obtained, maintained or submitted all material

reports, documents, forms, notices, applications and records, as required by any Applicable Laws or Authorizations and that all such

reports, documents, forms, notices, applications, and records, were complete and correct in all material respects on the date filed (or

were corrected or supplemented by a subsequent submission), except where the failure to file, obtain, maintain or submit would not, individually

or in the aggregate, reasonably be expected to result in a Material Adverse Change; and (G) has not, either voluntarily or involuntarily,

initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety

alert, post-sale warning, or other notice or action relating to the alleged lack of safety or any alleged product defect or violation

and, to the Company’s knowledge, no third party has initiated, conducted or intends to initiate any such notice or action.

2.36.

Environmental Matters.

2.36.1.

The business and operations of the Company, have been and are being conducted in compliance with all applicable laws, ordinances, rules,

regulations, licenses, permits, approvals, plans, authorizations or requirements relating to occupational safety and health, or pollution,

or protection of health or the environment (including, without limitation, those relating to emissions, discharges, releases or threatened

releases of pollutants, contaminants or hazardous or toxic substances, materials or wastes into ambient air, surface water, groundwater

or land, or relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of chemical

substances, pollutants, contaminants or hazardous or toxic substances, materials or wastes, whether solid, gaseous or liquid in nature)

of any governmental department, commission, board, bureau, agency or instrumentality of the United States, any state or political subdivision

thereof, or to the knowledge of the Company, any foreign jurisdiction (“Environmental Laws”), and all applicable judicial

or administrative agency or regulatory decrees, awards, judgments and orders relating thereto, except where the failure to be in such

compliance would not be reasonably expected, individually or in the aggregate, to have a Material Adverse Change; and the Company has

not received any notice from any governmental instrumentality or any third party alleging any material violation thereof or liability

thereunder (including, without limitation, liability for costs of investigating or remediating sites containing hazardous substances

and/or damages to natural resources).

2.36.2.

There has been no storage, generation, transportation, use, handling, treatment, Release or threat of Release of Hazardous Materials

(as defined below) by or caused by the Company (or, to the knowledge of the Company, any other entity (including any predecessor) for

whose acts or omissions the Company is or could reasonably be expected to be liable) at, on, under or from any property or facility now

or previously owned, operated or leased by the Company, or at, on, under or from any other property or facility, in violation of any

Environmental Laws or in a manner or amount or to a location that could reasonably be expected to result in any liability under any Environmental

Law, except for any violation or liability which would not, individually or in the aggregate, have a Material Adverse Change. “Hazardous

Materials” means any material, chemical, substance, waste, pollutant, contaminant, compound, mixture, or constituent thereof,

in any form or amount, including petroleum (including crude oil or any fraction thereof) and petroleum products, natural gas liquids,

asbestos and asbestos containing materials, naturally occurring radioactive materials, brine, and drilling mud, regulated or which can

give rise to liability under any Environmental Law. “Release” means any spilling, leaking, seepage, pumping, pouring,

emitting, emptying, discharging, injecting, escaping, leaching, dumping, disposing, depositing, dispersing, or migrating in, into or

through the environment, or in, into from or through any building or structure.

2.37.

Ineligible Issuer. At the time of filing the Registration Statement and any post-effective amendment thereto, at the time of effectiveness

of the Registration Statement and any amendment thereto, at the earliest time thereafter that the Company or another offering participant

made a bona fide offer (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Public Securities, and at the

date hereof, the Company was not and is not an “ineligible issuer,” as defined in Rule 405, without taking account of any

determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.

2.38.

Real and Personal Property. Except as set forth in the Registration Statement, the Disclosure Package and the Prospectus, the

Company has good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real or personal

property which are material to the business of the Company, in each case free and clear of all liens, encumbrances, security interests,

claims and defects that do not, singly or in the aggregate, materially affect the value of such property and do not interfere with the

use made and proposed to be made of such property by the Company; and all of the leases and subleases material to the business of the

Company, considered as one enterprise, and under which the Company holds properties described in the Registration Statement, the Disclosure

Package and the Prospectus, are in full force and effect, and the Company has not received any notice of any material claim of any sort

that has been asserted by anyone adverse to the rights of the Company under any of the leases or subleases mentioned above, or affecting

or questioning the rights of the Company to the continued possession of the leased or subleased premises under any such lease or sublease.

2.39.

Contracts Affecting Capital. There are no transactions, arrangements or other relationships between and/or among the Company,

any of its affiliates (as such term is defined in Rule 405 of the Securities Act Regulations) and any unconsolidated entity, including,

but not limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially

affect the Company’s liquidity or the availability of or requirements for their capital resources required to be described or incorporated

by reference in the Registration Statement, the Disclosure Package and the Prospectus which have not been described or incorporated by

reference as required.

2.40.

Loans to Directors or Officers. There are no outstanding loans, advances (except normal advances for business expenses in the

ordinary course of business) or guarantees or indebtedness by the Company to or for the benefit of any of the officers or directors of

the Company or any of their respective family members, except as disclosed in the Registration Statement, the Disclosure Package and

the Prospectus.

2.41.

Smaller Reporting Company. As of the time of filing of the Registration Statement, the Company was a “smaller reporting

company,” as defined in Rule 12b-2 of the Exchange Act Regulations.

2.42.

Industry Data. The statistical and market-related data included in each of the Registration Statement, the Disclosure Package

and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate

or represent the Company’s good faith estimates that are made on the basis of data derived from such sources.

2.43.

Testing-the-Waters Communications. The Company has not (i) alone engaged in any Testing-the-Waters Communications, other than

Testing-the-Waters Communications with the written consent of the Representative and with entities that are qualified institutional buyers

within the meaning of Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of Rule 501

under the Securities Act and (ii) authorized anyone other than the Representative to engage in Testing-the-Waters Communications. “Testing-the-Waters

Communication” means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the

Securities Act. The Company confirms that the Representative has been authorized to act on its behalf in undertaking Testing-the-Waters

Communications. The Company has not distributed any Written Testing-the-Waters Communications other than those listed on Schedule

2-B hereto. Schedule 2-B sets forth all Written Testing-the-Waters Communications used by the Company or on its behalf in

connection with the Offering. The Company has not distributed any Written Testing-the-Waters Communications other than those listed on

Schedule 2-B. “Written Testing-the-Waters Communication” means any Testing-the-Waters Communication that is

a written communication within the meaning of Rule 405 under the Securities Act.

2.44.

Margin Securities. The Company owns no “margin securities” as that term is defined in Regulation U of the Board of

Governors of the Federal Reserve System (the “Federal Reserve Board”), and none of the proceeds of Offering will be used,

directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness

which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the Common Stock

to be considered a “purpose credit” within the meanings of Regulation T, U or X of the Federal Reserve Board.

2.45.

Confidentiality and Non-Competition. To the Company’s knowledge, no director, officer, key employee or consultant of the

Company is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any employer

(other than the Company) or prior employer that could materially affect his or her ability to be and act in his or her respective capacity

of the Company or reasonably be expected to result in a Material Adverse Change.

2.46.

Corporate Records. The minute books of the Company have been made available to the Representative and Representative Counsel and

such books (i) contain minutes of all material meetings and actions of the Board of Directors (including each board committee) and stockholders

of the Company, and (ii) reflect all material transactions referred to in such minutes.

2.47.

Diligence Materials. The Company has provided to the Representative and Representative Counsel all materials required or necessary

to respond in all material respects to the diligence request submitted to the Company or its counsel by the Representative.

2.48.

Stabilization. Neither the Company nor, to its knowledge, any of its employees, directors or stockholders (without the consent

of the Representative) has taken, directly or indirectly, any action designed to or that has constituted or that might reasonably be

expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price of any

security of the Company to facilitate the sale or resale of the Public Securities.

2.49.

XBRL. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration

Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission’s

rules and guidelines applicable thereto.

2.50.

No Integrated Offering. Neither the Company, nor any Person acting on its behalf has, directly or indirectly, made any offers

or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Public

Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of the

Exchange.

2.51.

Solvency. Based on the financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company

of the proceeds from the sale of the Public Securities hereunder, (i) the fair saleable value of the Company’s assets exceeds the

amount that will be required to be paid on or in respect of the Company’s existing debts and other liabilities (including known

contingent liabilities) as they mature, (ii) the Company’s assets do not constitute unreasonably small capital to carry on its

business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements

of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)

the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after

taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when

such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature

(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any

facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization

laws of any jurisdiction within one year from the Closing Date. The SEC Reports set forth as of the date hereof all outstanding secured

and unsecured Indebtedness (as defined below) of the Company, or for which the Company has commitments. The Company is not in default

with respect to any Indebtedness. “Indebtedness” means (a) any liabilities for borrowed money or amounts owed in excess

of $100,000 (other than trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements and other

contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company’s

balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar

transactions in the ordinary course of business; and (c) the present value of any lease payments in excess of $100,000 due under leases

required to be capitalized in accordance with GAAP.

2.52.

U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within

the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Representative’s

request.

2.53.

Bank Holding Company Act. Neither the Company nor any of its Affiliates (as defined below) is subject to the Bank Holding Company

Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the

“Federal Reserve”). Neither the Company nor any of its Affiliates owns or controls, directly or indirectly, five percent

(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of

a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Affiliates

exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation

by the Federal Reserve. “Affiliate” means with respect to any Person, any other Person that, directly or indirectly

through one or more intermediaries, controls or is controlled by or is under common control with such Person as such terms are used in

and construed under Rule 405 under the Securities Act.

Covenants of the Company. The Company covenants and agrees as follows:

3.1.

Amendments to Registration Statement. Until the later of the Closing Date and the exercise in full or expiration of the Over-allotment

Option specified in Section 1.2 hereof, the Company shall deliver to the Representative, prior to filing, any amendment or supplement

to the Registration Statement or Prospectus proposed to be filed after the date of this Agreement and not file any such amendment or

supplement to which the Representative shall reasonably object in writing.

3.2.

Federal Securities Laws.

3.2.1.

Compliance. Until the later of the Closing Date and the exercise in full or expiration of the Over-allotment Option specified in Section

1.2 hereof, the Company, subject to Section 3.2.2, shall comply in all material respects with the requirements of Rule 430B of the Securities

Act Regulations, and will notify the Representative promptly, and confirm the notice in writing, (i) when any post-effective amendment

to the Registration Statement shall become effective or any amendment or supplement to the Prospectus shall have been filed; (ii) of

the receipt of any comments from the Commission; (iii) of any request by the Commission for any amendment to the Registration Statement

or any amendment or supplement to the Prospectus or for additional information; (iv) of the issuance by the Commission of any stop order

suspending the effectiveness of the Registration Statement or any post-effective amendment or of any order preventing or suspending the

use of the Prospectus, or of the suspension of the qualification of the Public Securities for offering or sale in any jurisdiction, or

of the initiation or threatening of any proceedings for any of such purposes or of any examination pursuant to Section 8(d) or 8(e) of

the Securities Act concerning the Registration Statement; and (v) if the Company becomes the subject of a proceeding under Section 8A

of the Securities Act in connection with the Offering of the Public Securities. The Company shall effect all filings required under Rule

424(b) of the Securities Act Regulations, in the manner and within the time period required by Rule 424(b) (without reliance on Rule

424(b)(8)), and shall take such steps as it deems reasonably necessary to ascertain promptly whether the form of prospectus transmitted

for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not, it will promptly file such

prospectus. The Company shall use its commercially reasonable efforts to prevent the issuance of any stop order, prevention or suspension

and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment.

3.2.2.

Continued Compliance. Until the later of the Closing Date and the exercise in full or expiration of the Over-allotment Option specified

in Section 1.2 hereof, the Company shall comply in all material respects with the Securities Act, the Securities Act Regulations, the

Exchange Act and the Exchange Act Regulations so as to permit the completion of the distribution of the Public Securities as contemplated

in this Agreement and in the Registration Statement, the Disclosure Package and the Prospectus. If at any time when a prospectus relating

to the Public Securities is (or, but for the exception afforded by Rule 172 of the Securities Act Regulations (“Rule 172”),

would be) required by the Securities Act to be delivered in connection with sales of the Public Securities, any event shall occur or

condition shall exist as a result of which it is necessary, in the opinion of counsel for the Underwriters or for the Company, to (i)

amend the Registration Statement in order that the Registration Statement will not include an untrue statement of a material fact or

omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii) amend or

supplement the Disclosure Package or the Prospectus in order that the Disclosure Package or the Prospectus, as the case may be, will

not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein

not misleading in the light of the circumstances existing at the time it is delivered to a purchaser; or (iii) amend the Registration

Statement or amend or supplement the Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements

of the Securities Act or the Securities Act Regulations, the Company will promptly (A) give the Representative notice of such event;

(B) prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the Registration Statement,

the Disclosure Package or the Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed filing

or use, furnish the Representative with copies of any such amendment or supplement; and (C) file with the Commission any such amendment

or supplement; provided that the Company shall not file or use any such amendment or supplement to which the Representative or Representative

Counsel shall reasonably object. The Company will furnish to the Underwriters such number of copies of such amendment or supplement as

the Underwriters may reasonably request. The Company has given the Representative notice of any filings made pursuant to the Exchange

Act or the Exchange Act Regulations within 48 hours prior to the Applicable Time. The Company shall give the Representative notice of

its intention to make any such filing from the Applicable Time until the later of the Closing Date and the exercise in full or expiration

of the Over-allotment Option specified in Section 1.2 hereof and will furnish the Representative with copies of the related document(s)

a reasonable amount of time prior to such proposed filing, as the case may be, and will not file or use any such document to which the

Representative or counsel for the Underwriters shall reasonably object.

3.2.3.

Exchange Act Registration. For a period of three (3) years after the date of this Agreement, the Company shall use its commercially

reasonable efforts to maintain the registration of the shares of Common Stock under the Exchange Act. The Company shall not deregister

the shares of Common Stock under the Exchange Act without the prior written consent of the Representative.

3.2.4.

Free Writing Prospectuses. The Company agrees that, unless it obtains the prior written consent of the Representative, it shall

not make any offer relating to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise

constitute a “free writing prospectus,” or a portion thereof, required to be filed by the Company with the Commission or

retained by the Company under Rule 433.

3.2.5.

Testing-the-Waters Communications. If at any time following the distribution of any Written Testing-the-Waters Communication there

occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include

an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein,

in the light of the circumstances existing at that subsequent time, not misleading, the Company shall promptly notify the Representative

and shall promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such

untrue statement or omission.

3.3.

Delivery to the Underwriters of Registration Statements. The Company has delivered or made available or shall deliver or make

available to the Representative and Representative Counsel, without charge, signed copies of the Registration Statement as originally

filed and each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates of experts,

and will also deliver to the Underwriters, upon request and without charge, a conformed copy of the Registration Statement as originally

filed and each amendment thereto (without exhibits) for each of the Underwriters. The copies of the Registration Statement and each amendment

thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant

to EDGAR, except to the extent permitted by Regulation S-T.

3.4.

Delivery to the Underwriters of Prospectuses. The Company has delivered or made available or will deliver or make available to

each Underwriter, without charge, as many copies of the Prospectus as such Underwriter reasonably requested, and the Company hereby consents

to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to each Underwriter, without charge,

during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule 172, would be) required

to be delivered under the Securities Act, such number of copies of the Prospectus (as amended or supplemented) as such Underwriter may

reasonably request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will be identical to the electronically

transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.

3.5.

Events Requiring Notice to the Representative. The Company shall notify the Representative promptly and confirm the notice in

writing: (i) of the issuance by any state securities commission of any proceedings for the suspension of the qualification of the Public

Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (ii)

of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration Statement or Prospectus;

(iii) of the receipt of any comments or request for any additional information from the Commission; and (iv) of the happening of any

event during the period described in this Section 3.5 that, in the judgment of the Company, makes any statement of a material fact made

in the Registration Statement, the Disclosure Package or the Prospectus untrue or that requires the making of any changes in (A) the

Registration Statement in order to make the statements therein not misleading, or (B) in the Disclosure Package or the Prospectus in

order to make the statements therein, in light of the circumstances under which they were made, not misleading.

3.6.

Press Releases. Prior to the Closing Date, the Company shall not issue any press release or other communication or hold any press

conference concerning the Company or the Offering without the prior written consent of the Representative, which consent shall not be

unreasonably withheld, unless, in the judgment of the Company and its counsel and after notice to the Representative, such communication

is required by applicable law.

3.7.

Review of Financial Statements. For a period of three (3) years after the date of this Agreement, the Company, at its expense,

shall cause its regularly engaged independent registered public accounting firm to review (but not audit) the Company’s financial

statements for each of the three fiscal quarters immediately preceding the announcement of any quarterly financial information.

3.8.

Listing. The Company shall use its commercially reasonable efforts to maintain the listing of the shares of Common Stock (including

the Public Securities) on the Exchange for at least three (3) years from the date of this Agreement.

3.9.

Reports to the Representative.

3.9.1.

Periodic Reports, etc. For a period of not less than one (1) year after the date of this Agreement, the Company shall furnish

or make available to the Representative copies of such financial statements and other periodic and special reports as the Company from

time to time furnishes generally to holders of any class of its securities and also promptly furnish to the Representative: (i) a copy

of each periodic report the Company shall be required to file with the Commission under the Exchange Act and the Exchange Act Regulations;

(ii) a copy of every press release and every news item and article with respect to the Company or its affairs which was released by the

Company; (iii) a copy of each Current Report on Form 8-K prepared and filed by the Company; (iv) five copies of each registration statement

filed by the Company under the Securities Act; and (v) such additional documents and information with respect to the Company and the

affairs of any future subsidiaries of the Company as the Representative may from time to time reasonably request; provided the Representative

shall sign, if requested by the Company, a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative

and Representative Counsel in connection with the Representative’s receipt of such information. Documents filed with the Commission

pursuant to its EDGAR system shall be deemed to have been delivered to the Representative pursuant to this Section 3.8.1.

3.9.2.

Transfer Agent; Transfer Sheets. For a period of one (1) year after the date of this Agreement, the Company shall retain a transfer

agent and registrar acceptable to the Representative (the “Transfer Agent”) and shall furnish to the Representative

at the Company’s sole cost and expense such transfer sheets of the Company’s securities as the Representative may reasonably

request, including the daily and monthly consolidated transfer sheets of the Transfer Agent and DTC. Securitize, LLC, formerly Pacific

Stock Transfer Company, is acceptable to the Representative to act as Transfer Agent for the shares of Common Stock.

3.10.

Payment of Expenses

3.10.1.

General Expenses Related to the Offering. The Company hereby agrees to pay on each of the Closing Date and the Option Closing

Date, if any, to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company

under this Agreement, including, but not limited to: (a) all filing fees and communication expenses relating to the registration of the

shares of Common Stock to be sold in the Offering (including the Option Shares) with the Commission; (b) all Public Filing System filing

fees associated with the review of the Offering by FINRA; (c) all fees and expenses relating to the listing of such Public Securities

on the Exchange and such other stock exchanges as the Company and the Representative together determine; (d) all fees, expenses and disbursements

relating to background checks of the Company’s officers and directors; (e) all fees, expenses and disbursements, if any, relating

to the registration or qualification of the Public Securities under the “blue sky” securities laws of such states and other

jurisdictions as the Representative may reasonably designate, as applicable; (f) all fees, expenses and disbursements relating to the

registration, qualification or exemption of the Public Securities under the securities laws of such foreign jurisdictions as the Representative

may reasonably designate; (g) the costs of all mailing and printing of the underwriting documents (including, without limitation, the

Underwriting Agreement, any Blue Sky Surveys and, if appropriate, any Agreement Among Underwriters, Selected Dealers’ Agreement,

Underwriters’ Questionnaire and Power of Attorney), Registration Statements, Prospectuses and all amendments, supplements and exhibits

thereto and as many preliminary and final Prospectuses as the Representative may reasonably deem necessary; (h) the costs of preparing,

printing and delivering certificates representing the Public Securities; (i) fees and expenses of the Transfer Agent for the shares of

Common Stock; (j) stock transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company to the Underwriters;

(k) the cost associated with the Underwriter’s use of book-building and compliance software for the Offering; (l) [reserved]; (m)

the fees and expenses of the Company’s accountants; (n) the fees and expenses of the Company’s legal counsel and other agents

and representatives; and (o) the fees and expenses of the Representative Counsel; provided, that the maximum amount that the Company

shall pay for items (d), (k), (l), and (o) and shall be $35,000. The Representative may deduct from the net proceeds of the Offering

payable to the Company on the Closing Date, or the Option Closing Date, if any, the expenses set forth herein to be paid by the Company

to the Underwriters, other than amounts already advanced to the Representative as of the date of this Underwriting Agreement.

3.11.

Application of Net Proceeds. The Company shall apply the net proceeds from the Offering received by it in a manner consistent

with the application thereof described under the caption “Use of Proceeds” in the Registration Statement, the Disclosure

Package and the Prospectus.

3.12.

Delivery of Earnings Statements to Security Holders. The Company shall make generally available to its security holders as soon

as practicable, but not later than the first day of the fifteenth (15th) full calendar month following the date of this Agreement, an

earnings statement (which need not be certified by independent registered public accounting firm unless required by the Securities Act

or the Securities Act Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities Act) covering

a period of at least twelve (12) consecutive months beginning after the date of this Agreement.

3.13.

Stabilization. Neither the Company, nor, to its knowledge, any of its employees, directors or shareholders (without the

consent of the Representative) has taken or will take, directly or indirectly, any action designed to or that has constituted or that

might reasonably be expected to cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price

of any security of the Company to facilitate the sale or resale of the Public Securities.

3.14.

Internal Controls. The Company shall use commercially reasonable efforts to maintain a system of internal accounting controls

for itself sufficient to provide reasonable assurances that: (i) transactions are executed in accordance with management’s general

or specific authorization; (ii) transactions are recorded as necessary in order to permit preparation of financial statements in accordance

with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general

or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and

appropriate action is taken with respect to any differences.

3.15.

Accountants. As of the date of this Agreement, the Company has retained an independent registered public accounting firm reasonably

acceptable to the Representative, and the Company shall continue to retain an independent registered public accounting firm for a period

of at least three (3) years after the date of this Agreement. The Representative acknowledges that the Auditor is acceptable to the Representative.

3.16.

FINRA. The Company shall advise the Representative (who shall make an appropriate filing with FINRA) if it is or becomes aware

that (i) any officer or director of the Company, (ii) any beneficial owner of 5% or more of any class of the Company’s securities

or (iii) any beneficial owner of the Company’s unregistered equity securities which were acquired during the 180 days immediately

preceding the filing of the Registration Statement, is or becomes an affiliate or associated person of a FINRA member participating in

the Offering (as determined in accordance with the rules and regulations of FINRA).

3.17.

No Fiduciary Duties. The Company acknowledges and agrees that the Underwriters’ responsibility to the Company is solely

contractual in nature and that none of the Underwriters or their affiliates or any selling agent shall be deemed to be acting in a fiduciary

capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other

transactions contemplated by this Agreement.

3.18.

Company Lock-Up Agreements.

3.18.1.

Restriction on Sale of Capital Stock. The Company, on behalf of itself and any successor entity, agrees that, without the prior

written consent of the Representative, it will not, for a period of ninety (90) days after the date of this Agreement (the “Lock-Up

Period”), (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract

to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares

of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the

Company; or (ii) complete any offering of debt securities of the Company (other than debt securities convertible into shares of Common

Stock of the Company); or (iii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic

consequences of ownership of capital stock of the Company, whether any such transaction described in clause (i) or (ii) above is to be

settled by delivery of shares of capital stock of the Company or such other securities, in cash or otherwise.

The

restrictions contained in this Section 3.18.1 shall not apply to (i) the shares of Common Stock to be sold hereunder, (ii) the issuance

by the Company of shares of Common Stock upon the exercise of a stock option or warrant or the conversion of a security outstanding on

the date hereof, of which the Representative has been advised in writing, (iii) resales of shares of Common Stock to be sold upon the

filing of a registration statement on Form S-1 or Form S-3 filed with the Commission, (iv) the issuance by the Company of stock options

or shares of capital stock of the Company under any equity compensation plan of the Company or (v) the filing of a registration statement

on Form S-8 with the Commission.

Notwithstanding

the foregoing, if (i) during the last seventeen (17) days of the Lock-Up Period, the Company issues an earnings release or material news

or a material event relating to the Company occurs, or (ii) prior to the expiration of the Lock-Up Period, the Company announces that

it will release earnings results or becomes aware that material news or a material event will occur during the 16-day period beginning

on the last day of the Lock-Up Period, the restrictions imposed by this Section 3.18.1 shall continue to apply until the expiration of

the 18-day period beginning on the issuance of the earnings release or the occurrence of such material news or material event, as applicable,

unless the Representative waives, in writing, such extension; provided, however, that this extension of the Lock-Up Period shall not

apply to the extent that FINRA has otherwise provided written interpretive guidance regarding such rule, in each case, so as to eliminate

the prohibition of any broker, dealer, or member of a national securities association from publishing or distributing any research report,

with respect to the securities of an Emerging Growth Company prior to or after the expiration of any agreement between the broker, dealer,

or member of a national securities association and the Emerging Growth Company or its stockholders that restricts or prohibits the sale

of securities held by the Emerging Growth Company or its stockholders after the initial public offering date.

3.18.2.

Restriction on Continuous Offerings. Notwithstanding the restrictions contained in Section 3.18.1, the Company, on behalf of itself

and any successor entity, agrees that, without the prior written consent of the Representative, it will not, for a period of 6 months

after the date of this Agreement, directly or indirectly in any “at-the-market” or continuous equity transaction, offer to

sell, sell, contract to sell, grant any option to sell or otherwise dispose of shares of capital stock of the Company or any securities

convertible into or exercisable or exchangeable for shares of capital stock of the Company.

3.19.

Release of D&O Lock-up Period. If the Representative, in its sole discretion, agrees to release or waive the restrictions

set forth in the Lock-Up Agreements described in Section 2.24 hereof for an officer or director of the Company and provides the Company

with notice of the impending release or waiver at least three (3) Business Days before the effective date of the release or waiver, the

Company agrees to announce the impending release or waiver by a press release substantially in the form of Exhibit C hereto through a

major news service at least two (2) Business Days before the effective date of the release or waiver.

3.20.

Blue Sky Qualifications. The Company shall use its commercially reasonable efforts, in cooperation with the Underwriters, if necessary,

to qualify the Public Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic

or foreign) as the Representative may designate and to maintain such qualifications in effect so long as required to complete the distribution

of the Public Securities; provided, however, that the Company shall not be obligated to file any general consent to service of process

or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject

itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.

3.21.

Reporting Requirements. The Company, during the period when a prospectus relating to the Public Securities is (or, but for the

exception afforded by Rule 172, would be) required to be delivered under the Securities Act, will use its commercially reasonable efforts

to file all documents required to be filed with the Commission pursuant to the Exchange Act within the time periods required by the Exchange

Act and Exchange Act Regulations. Additionally, the Company shall report the use of proceeds from the issuance of the Public Securities

as may be required under Rule 463 under the Securities Act Regulations.

3.22.

Emerging Growth Company Status. The Company shall promptly notify the Representative if the Company ceases to be an Emerging Growth

Company at any time prior to the later of (i) completion of the distribution of the Public Securities within the meaning of the Securities

Act and (ii) fifteen (15) days following the completion of the Lock-Up Period.

3.23.

[Reserved].

3.24.

Shareholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,

that any Underwriter of the Public Securities is an “Acquiring Person” under any control share acquisition, business combination,

poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter

adopted by the Company, or that any Underwriter of Public Securities could be deemed to trigger the provisions of any such plan or arrangement,

by virtue of receiving Public Securities except if and to the extent required by applicable law.

3.25.

Reservation of Common Stock. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep

available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company

to issue Option Shares pursuant to the Over-Allotment Option.

3.26.

[Reserved].

3.27.

[Reserved].

3.28.

Listing Application. The Company has timely submitted to Nasdaq all notifications and applications required in connection with

the listing of the Firm Shares, including any Listing of Additional Shares notification.

Conditions of Underwriters’ Obligations. The obligations of the Underwriters to purchase and pay for the Public Securities,

as provided herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of the date

hereof and as of each of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of officers of the

Company made pursuant to the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the following

conditions:

4.1.

Regulatory Matters.

4.1.1.

Commission Actions; Required Filings. At the Closing Date and any Option Closing Date, no stop order suspending the effectiveness of

the Registration Statement or any post-effective amendment thereto shall have been issued under the Securities Act, no order preventing

or suspending the use of the Disclosure Package or the Prospectus shall have been issued and no proceedings for any such purpose shall

have been instituted or be pending or, to the Company’s knowledge, contemplated by the Commission. The Prospectus containing the

Rule 430B Information shall have been filed with the Commission within the time period required by Rule 424(b) under the Securities Act

Regulations.

4.1.2.

FINRA Clearance. On or before the date of this Agreement, the Representative shall have received confirmation that the Offering

has been cleared by FINRA as to the amount of compensation allowable or payable to the Underwriters as described in the Registration

Statement or is exempt from filing with or review by FINRA, as applicable.

4.1.3.

Exchange Stock Market Clearance. On the Closing Date, the Company’s shares of Common Stock, including the Firm Shares, shall

have been approved for listing on the Exchange, subject only to official notice of issuance. On the first Option Closing Date (if any),

the Company’s shares of Common Stock, including the Option Shares, shall have been approved for listing on the Exchange, subject

only to official notice of issuance.

4.2.

Company Counsel Matters.

4.2.1.

Closing Date Opinions of Counsel. On the Closing Date, the Representative shall have received the favorable opinions of Pachulski

Stang Ziehl & Jones LLP, counsel to the Company, dated the Closing Date and addressed to the Representative and in form and substance

reasonably satisfactory to the Representative.

4.2.2.

Option Closing Date Opinions of Counsel. On the Option Closing Date, if any, the Representative shall have received the favorable

opinion of counsel listed in Section 4.2.1, dated the Option Closing Date, addressed to the Representative and in form and substance

reasonably satisfactory to the Representative, confirming as of the Option Closing Date, the statements made by such counsel in their

opinion delivered on the Closing Date.

4.3.

Reliance. In rendering such opinions, such counsel may rely: (i) as to matters involving the application of laws other than the

laws of the United States and jurisdictions in which they are admitted, to the extent such counsel deems proper and to the extent specified

in such opinion, if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to the Representative) of other

counsel reasonably acceptable to the Representative, familiar with the applicable laws; and (ii) as to matters of fact, to the extent

they deem proper, on certificates or other written statements of officers of the Company and officers of departments of various jurisdictions

having custody of documents respecting the corporate existence or good standing of the Company, provided that copies of any such statements

or certificates shall be delivered to Representative Counsel if requested.

4.4.

[Reserved].

4.5.

Officers’ Certificates.

4.5.1.

Officers’ Certificate. The Company shall have furnished to the Representative a certificate, dated the Closing Date and any Option

Closing Date (if such date is other than the Closing Date), of its Chief Executive Officer and its Chief Financial Officer stating that

(i) such officers have carefully examined the Registration Statement, the Disclosure Package, any Issuer Free Writing Prospectus and

the Prospectus and, in their opinion, the Registration Statement and each amendment thereto, as of the Applicable Time and as of the

Closing Date (or any Option Closing Date if such date is other than the Closing Date) did not include any untrue statement of a material

fact and did not omit a material fact required to be stated therein or necessary to make the statements therein not misleading, and the

Disclosure Package, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing

Date), any Issuer Free Writing Prospectus as of its date and as of the Closing Date (or any Option Closing Date if such date is other

than the Closing Date), the Prospectus and each amendment or supplement thereto, as of the respective date thereof and as of the Closing

Date, did not include any untrue statement of a material fact and did not omit to state a material fact necessary in order to make the

statements therein, in the light of the circumstances in which they were made, not misleading, (ii) since the effective date of the Registration

Statement, no event has occurred which should have been set forth in a supplement or amendment to the Registration Statement, the Disclosure

Package or the Prospectus, (iii) to their knowledge, after reasonable inquiry, as of the Closing Date (or any Option Closing Date if

such date is other than the Closing Date), the representations and warranties of the Company in this Agreement are true and correct and

the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior

to the Closing Date (or any Option Closing Date if such date is other than the Closing Date), and (iv) there has not been, subsequent

to the date of the most recent audited financial statements included or incorporated by reference in the Disclosure Package, any material

adverse change in the financial position or results of operations of the Company, or any change or development that, singularly or in

the aggregate, would involve a material adverse change or a prospective material adverse change, in or affecting the condition (financial

or otherwise), results of operations, business, assets or prospects of the Company, except as set forth in the Prospectus.

4.5.2.

Secretary’s Certificate. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have

received a certificate of the Company signed by the Secretary of the Company, dated the Closing Date or the Option Closing Date, as the

case may be, respectively, certifying: (i) that each of the Charter and Bylaws is true and complete, has not been modified and is in

full force and effect; (ii) that the resolutions of the Company’s Board of Directors relating to the Offering are in full force

and effect and have not been modified; and (iii) as to the incumbency of the officers of the Company. The documents referred to in such

certificate shall be attached to such certificate.

4.5.3.

Chief Financial Officer’s Certificate. At each of the Closing Date and the Option Closing Date, if any, the Representative

shall have received a certificate of the Chief Financial Officer of the Company, dated the Closing Date or the Option Closing Date, as

applicable, with respect to the accuracy of specified financial and accounting information contained or incorporated by reference in

the Registration Statement, the Disclosure Package and the Prospectus, in form and substance reasonably satisfactory to the Representative

and Representative Counsel.

4.6.

No Material Changes. Prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been

no Material Adverse Change or development involving a prospective Material Adverse Change in the condition or prospects or the business

activities, financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the Registration

Statement, the Disclosure Package and the Prospectus; (ii) no action, suit or proceeding, at law or in equity, shall have been pending,

or to the Company’s knowledge, threatened against the Company or any Insider before or by any court or federal or state commission,

board or other administrative agency wherein an unfavorable decision, ruling or finding may result in a Material Adverse Change, except

as set forth in the Registration Statement, the Disclosure Package and the Prospectus; (iii) no stop order shall have been issued under

the Securities Act and no proceedings therefor shall have been initiated or threatened by the Commission; and (iv) the Registration Statement,

the Disclosure Package and the Prospectus and any amendments or supplements thereto shall contain all material statements which are required

to be stated therein in accordance with the Securities Act and the Securities Act Regulations and shall conform in all material respects

to the requirements of the Securities Act and the Securities Act Regulations, and neither the Registration Statement, the Disclosure

Package nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state

any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which

they were made, not misleading.

4.7.

Delivery of Lock-Up Agreements. On or before the date of this Agreement, the Company shall have delivered to the Representative

executed copies of the Lock-Up Agreements from each of the persons listed in Schedule 3 hereto.

4.8.

Additional Documents. At the Closing Date and at each Option Closing Date (if any) Representative Counsel shall have been furnished

with such documents and opinions as they may reasonably require in order to evidence the accuracy of any of the representations or warranties,

or the fulfillment of any of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance

and sale of the Public Securities as herein contemplated shall be satisfactory in form and substance to the Representative and Representative

Counsel.

Indemnification.

5.1.

Indemnification of the Underwriters.

5.1.1.

General. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless each Underwriter, its affiliates

and each of its and their respective directors, officers, members, employees, representatives and agents and each person, if any, who

controls any such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively

the “Underwriter Indemnified Parties,” and each an “Underwriter Indemnified Party”), against any and all loss,

liability, claim, damage and expense whatsoever (including but not limited to any and all legal or other expenses documented and reasonably

incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising

out of any action between any of the Underwriter Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties

and any third party, or otherwise) to which they or any of them may become subject under the Securities Act, the Exchange Act or any

other statute or at common law or otherwise or under the laws of foreign countries, arising out of or based upon any untrue statement

or alleged untrue statement of a material fact contained in (i) the Registration Statement, the Disclosure Package, the Prospectus, or

in any Issuer Free Writing Prospectus or in any Written Testing-the-Waters Communication (as from time to time each may be amended and

supplemented); (ii) any materials or information provided to investors by, or with the approval of, the Company in connection with the

marketing of the Offering, including any “road show” or investor presentations made to investors by the Company (whether

in person or electronically); or (iii) any application or other document or written communication (in this Section 5, collectively called

“application”) executed by the Company or based upon written information furnished by the Company in any jurisdiction in

order to qualify the Public Securities under the securities laws thereof or filed with the Commission, any state securities commission

or agency, the Exchange or any other national securities exchange; or the omission or alleged omission therefrom of a material fact required

to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading,

unless such statement or omission was made in reliance upon, and in conformity with, the Underwriters’ Information. With respect

to any untrue statement or omission or alleged untrue statement or omission made in the Disclosure Package, the indemnity agreement contained

in this Section 5.1.1 shall not inure to the benefit of any Underwriter Indemnified Party to the extent that any loss, liability, claim,

damage or expense of such Underwriter Indemnified Party results from the fact that a copy of the Prospectus was not given or sent to

the person asserting any such loss, liability, claim or damage at or prior to the written confirmation of sale of the Public Securities

to such person as required by the Securities Act and the Securities Act Regulations, and if the untrue statement or omission has been

corrected in the Prospectus, unless such failure to deliver the Prospectus was a result of non-compliance by the Company with its obligations

under Section 3.3 hereof.

5.1.2.

Procedure. If any action is brought against an Underwriter Indemnified Party in respect of which indemnity may be sought against

the Company pursuant to Section 5.1.1, such Underwriter Indemnified Party shall promptly notify the Company in writing of the institution

of such action and the Company shall assume the defense of such action, including the employment and fees of counsel (subject to the

reasonable approval of such Underwriter Indemnified Party) and payment of actual expenses. Such Underwriter Indemnified Party shall have

the right to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such

Underwriter Indemnified Party unless (i) the employment of such counsel at the expense of the Company shall have been authorized in writing

by the Company in connection with the defense of such action, or (ii) the Company shall not have employed counsel to have charge of the

defense of such action within a reasonable time after receipt by the Company of notice of the institution of such action, or (iii) such

indemnified party or parties shall have reasonably concluded that there may be defenses available to it or them which are different from

or additional to those available to the Company (in which case the Company shall not have the right to direct the defense of such action

on behalf of the indemnified party or parties), in any of which events the reasonable fees and expenses of not more than one additional

firm of attorneys selected by the Underwriter Indemnified Party (in addition to local counsel) shall be borne by the Company. Notwithstanding

anything to the contrary contained herein, if any Underwriter Indemnified Party shall assume the defense of such action as provided above,

the Company shall have the right to approve the terms of any settlement of such action, which approval shall not be unreasonably withheld.

5.2.

Indemnification of the Company. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company,

its directors, its officers who signed the Registration Statement and persons who control the Company within the meaning of Section 15

of the Securities Act or Section 20 of the Exchange Act, against any and all loss, liability, claim, damage and expense described in

the foregoing indemnity from the Company to the several Underwriters, as incurred, but only with respect to untrue statements or omissions,

or alleged untrue statements or omissions made in the Registration Statement, the Disclosure Package or Prospectus or any amendment or

supplement thereto or in any application, in reliance upon, and in strict conformity with, the Underwriters’ Information. In case

any action shall be brought against the Company or any other person so indemnified based on the Registration Statement, the Disclosure

Package or Prospectus or any amendment or supplement thereto or any application, and in respect of which indemnity may be sought against

any Underwriter, such Underwriter shall have the rights and duties given to the Company, and the Company and each other person so indemnified

shall have the rights and duties given to the several Underwriters by the provisions of Section 5.1.2. The Company agrees to promptly

notify the Representative of the commencement of any litigation or proceedings against the Company or any of its officers, directors

or any person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange

Act, in connection with the issuance and sale of the Public Securities or in connection with the Registration Statement, the Disclosure

Package, the Prospectus, or any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication.

5.3.

Contribution.

5.3.1.

Contribution Rights. If the indemnification provided for in this Section 5 shall for any reason be unavailable to or insufficient

to hold harmless an indemnified party under Section 5.1 or 5.2 in respect of any loss, claim, damage or liability, or any action in respect

thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount

paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, (i) in

such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters,

on the other, from the Offering of the Public Securities, or (ii) if the allocation provided by clause (i) above is not permitted by

applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also

the relative fault of the Company, on the one hand, and the Underwriters, on the other, with respect to the statements or omissions that

resulted in such loss, claim, damage or liability, or action in respect thereof, as well as any other relevant equitable considerations.

The relative benefits received by the Company, on the one hand, and the Underwriters, on the other, with respect to such Offering shall

be deemed to be in the same proportion as the total net proceeds from the Offering of the Public Securities purchased under this Agreement

(before deducting expenses) received by the Company, as set forth in the table on the cover page of the Prospectus, on the one hand,

and the total underwriting discounts and commissions received by the Underwriters with respect to the shares of the Common Stock purchased

under this Agreement, as set forth in the table on the cover page of the Prospectus, on the other hand. The relative fault shall be determined

by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material

fact relates to information supplied by the Company or the Underwriters, the intent of the parties and their relative knowledge, access

to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would

not be just and equitable if contributions pursuant to this Section 5.3.1 were to be determined by pro rata allocation (even if the Underwriters

were treated as one entity for such purpose) or by any other method of allocation that does not take into account the equitable considerations

referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action

in respect thereof, referred to above in this Section 5.3.1 shall be deemed to include, for purposes of this Section 5.3.1, all documented

and reasonably incurred legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending

any such action or claim. Notwithstanding the provisions of this Section 5.3.1 in no event shall an Underwriter be required to contribute

any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect

to the Offering of the Public Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by

reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within

the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent

misrepresentation.

5.3.2.

Contribution Procedure. Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of notice

of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made

against another party (“contributing party”), notify the contributing party of the commencement thereof, but the failure

to so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution

hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or

its representative of the commencement thereof within the aforesaid 15 days, the contributing party will be entitled to participate therein

with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable to any

party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution

on account of any settlement of any claim, action or proceeding affected by such party seeking contribution without the written consent

of such contributing party. The contribution provisions contained in this Section 5.3.2 are intended to supersede, to the extent permitted

by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available. Each Underwriter’s obligations

to contribute pursuant to this Section 5.3 are several and not joint.

Defaults.

6.1.

Default by an Underwriter.

6.1.1.

Default Not Exceeding 10% of Firm Shares or Option Shares. If any Underwriter or Underwriters shall default in its or their obligations

to purchase the Firm Shares or the Option Shares, if the Over-allotment Option is exercised hereunder, and if the number of the Firm

Shares or Option Shares with respect to which such default relates does not exceed in the aggregate 10% of the number of Firm Shares

or Option Shares that all Underwriters have agreed to purchase hereunder, then such Firm Shares or Option Shares to which the default

relates shall be purchased by the non-defaulting Underwriters in proportion to their respective commitments hereunder.

6.1.2.

Default Exceeding 10% of Firm Shares or Option Shares. In the event that the default addressed in Section 6.1 relates to more

than 10% of the Firm Shares or Option Shares, the Representative may in its discretion arrange for themselves or for another party or

parties to purchase such Firm Shares or Option Shares to which such default relates on the terms contained herein. If, within one (1)

Business Day after such default relating to more than 10% of the Firm Shares or Option Shares, the Representative does not arrange for

the purchase of such Firm Shares or Option Shares, then the Company shall be entitled to a further period of one (1) Business Day within

which to procure another party or parties reasonably satisfactory to the Representative to purchase said Firm Shares or Option Shares

on such terms. In the event that neither the Representative nor the Company arrange for the purchase of the Firm Shares or Option Shares

to which a default relates as provided in this Section 6, this Agreement will automatically be terminated by the Representative or the

Company without liability on the part of the Company (except as provided in Sections 3.8 and 5 hereof) or the several Underwriters (except

as provided in Section 5 hereof); provided, however, that if such default occurs with respect to the Option Shares, this Agreement will

not terminate as to the Firm Shares; and provided, further, that nothing herein shall relieve a defaulting Underwriter of its liability,

if any, to the other Underwriters and to the Company for damages occasioned by its default hereunder.

6.1.3.

Postponement of Closing Date. In the event that the Firm Shares or Option Shares to which the default relates are to be purchased by

the non-defaulting Underwriters, or are to be purchased by another party or parties as aforesaid, the Representative or the Company shall

have the right to postpone the Closing Date or Option Closing Date for a reasonable period, but not in any event exceeding five (5) Business

Days, in order to effect whatever changes may thereby be made necessary in the Registration Statement, the Disclosure Package or the

Prospectus or in any other documents and arrangements, and the Company agrees to file promptly any amendment to the Registration Statement,

the Disclosure Package or the Prospectus that in the opinion of counsel for the Underwriter may thereby be made necessary. The term “Underwriter”

as used in this Agreement shall include any party substituted under this Section 6 with like effect as if it had originally been a party

to this Agreement with respect to such shares of Common Stock.

Additional Covenants.

7.1.

Board Composition and Board Designations. The Company shall use commercially reasonable efforts so that: (i) the qualifications

of the persons serving as members of the Board of Directors and the overall composition of the Board comply with the Sarbanes-Oxley Act,

with the Exchange Act and with the listing rules of the Exchange or any other national securities exchange, as the case may be, in the

event the Company seeks to have its Public Securities listed on another exchange or quoted on an automated quotation system, and (ii)

if applicable, at least one member of the Audit Committee of the Board of Directors qualifies as an “audit committee financial

expert,” as such term is defined under Regulation S-K and the listing rules of the Exchange; provided, however, that the Representative

and the Underwriters acknowledge that as of the date hereof, no member of the Audit Committee of the Board of Directors qualifies as

an “audit committee financial expert”.

7.2.

Prohibition on Press Releases and Public Announcements. The Company shall not issue press releases or engage in any other publicity

without the Representative’s prior written consent (which consent shall not be unreasonably withheld), for a period ending at 5:00

p.m., Eastern time, on the first (1st) Business Day following the forty-fifth (45th) day after the Closing Date, other than normal and

customary releases issued in the ordinary course of the Company’s business.

Effective Date of this Agreement and Termination Thereof.

8.1.

Effective Date. This Agreement shall become effective when both the Company and the Representative have executed the same and

delivered counterparts of such signatures to the other party.

8.2.

Termination. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i) if

any domestic or international event or act or occurrence has materially disrupted, or in the Representative’s reasonable opinion

will in the immediate future materially disrupt, general securities markets in the United States; or (ii) if trading on the New York

Stock Exchange or the Nasdaq Stock Market LLC shall have been suspended or materially limited, or minimum or maximum prices for trading

shall have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or

any other government authority having jurisdiction; or (iii) if the United States shall have become involved in a new war or an increase

in major hostilities; or (iv) if a banking moratorium has been declared by a New York State or federal authority; or (v) if a moratorium

on foreign exchange trading has been declared which materially adversely impacts the United States securities markets; or (vi) if the

Company shall have sustained a material loss by fire, flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious

act which, whether or not such loss shall have been insured, will, in the Representative’s reasonable opinion, make it inadvisable

to proceed with the delivery of the Firm Shares or Option Shares; or (vii) if the Company is in material breach of any of its representations,

warranties or covenants hereunder; or (viii) if the Representative shall have become aware after the date hereof of such a material adverse

change in the conditions or prospects of the Company, or such adverse material change in general market conditions as in the Representative’s

reasonable judgment would make it impracticable to proceed with the offering, sale and/or delivery of the Public Securities or to enforce

contracts made by the Underwriters for the sale of the Public Securities.

8.3.

Expenses. Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters, pursuant

to Section 6.1.2 above, in the event that this Agreement shall not be carried out for any reason whatsoever, within the time specified

herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Underwriters their actual

and accountable out-of-pocket expenses related to the transactions contemplated herein then due and payable (including the fees and disbursements

of Representative Counsel) up to an aggregate of $50,000, inclusive of any advance for accountable expenses previously paid by the Company

to the Representative (the “Advance”) and upon demand the Company shall pay the full amount thereof to the Representative

on behalf of the Underwriters; provided, however, that such expense cap in no way limits or impairs the indemnification and contribution

provisions of this Agreement. Notwithstanding the foregoing, any advance received by the Representative will be reimbursed to the Company

to the extent not actually incurred in compliance with FINRA Rule 5110(f)(2)(C).

8.4.

Indemnification. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination

of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Section 5 shall remain in full force

and effect and shall not be in any way affected by, such election or termination or failure to carry out the terms of this Agreement

or any part hereof.

8.5.

Representations, Warranties, Agreements to Survive. All representations, warranties and agreements contained in this Agreement

or in certificates of officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless

of (i) any investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter,

its officers or directors or any person controlling the Company or (ii) delivery of and payment for the Public Securities.

Miscellaneous.

9.1.

Notices. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed

(registered or certified mail, return receipt requested), personally delivered or sent by facsimile transmission or email with confirmation

and shall be deemed given when so delivered or faxed or emailed with confirmation or if mailed, two (2) days after such mailing.

to the Representative:

Lake

Street Capital Markets LLC

121 South 8th Street, Suite 1000

Minneapolis, Minnesota 55402

Attention: Paul McNamee, Chief Compliance Officer

Email: paul.mcnamee@lakestreetcm.com

with

a copy (which shall not constitute notice) to:

Sullivan

& Worcester LLP

1251 Avenue of the Americas

New York, New York 10020

Attn: David E. Danovitch, Esq.

Email: ddanovitch@sullivanlaw.com

to the Company:

BranchOut

Food Inc.

205 SE Davis Ave., Suite C

Bend,

Oregon 97702

Attention: Eric Healy, Chief Executive Officer

Email: eric@branchoutfood.com

with

copies (which shall not constitute notice) to:

Pachulski

Stang Ziehl & Jones LLP

1700

Broadway, 36th Floor New York, NY 10019

Attention:

Zev Bomrind, Esq.

Email:

zbomrind@pszjlaw.com

9.2.

Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or

affect the meaning or interpretation of any of the terms or provisions of this Agreement.

9.3.

Amendment. This Agreement may only be amended by a written instrument executed by each of the parties hereto.

9.4.

Entire Agreement. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection

with this Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and

supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

9.5.

Binding Effect. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters,

the Company, the controlling persons, directors and officers referred to in Section 5 hereof, and their respective successors, legal

representatives, heirs and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim

under or in respect of or by virtue of this Agreement or any provisions herein contained. The term “successors and assigns”

shall not include a purchaser, in its capacity as such, of securities from any of the Underwriters.

9.6.

Governing Law; Consent to Jurisdiction; Trial by Jury. This Agreement shall be governed by and construed and enforced in accordance

with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that

any action, proceeding or claim against it arising out of, or relating in any way to this Agreement shall be brought and enforced in

the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably

submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction

and that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company may be served by transmitting

a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in

Section 9.1 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding

or claim. The Company agrees that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies)

all of its reasonable attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection with the

preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates)

and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial

by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.

9.7.

Execution in Counterparts. This Agreement may be executed in one or more counterparts, and by the different parties hereto in

separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the

same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered

to each of the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall

constitute valid and sufficient delivery thereof.

9.8.

Waiver, etc. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not

be deemed or construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision

hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach,

non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument

executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance

or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.

[Signature

Page Follows]

the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided

below for that purpose, whereupon this Agreement shall constitute a binding agreement between us.

Very

truly yours,

BRANCHOUT

FOOD INC.

By: /s/

Eric Healy

Eric

Healy

Chief

Executive Officer

Confirmed

as of the date first written above mentioned,

on behalf of itself and as Representative of the several

Underwriters named on Schedule 1 hereto:

LAKE STREET CAPITAL

MARKETS LLC

By: /s/

Mike Townley

Mike

Townley

Head

of Investment Banking

[BranchOut

Food Inc. - Underwriting Agreement Signature Page]

SCHEDULE

Underwriter

Total

Number of

Firm

Shares to be

Purchased

Number

Option

be Purchased if

the

Over-

Allotment

Option

Fully Exercised

Lake

Street Capital Markets LLC

2,941,177

441,176

TOTAL

2,941,177

441,176

SCHEDULE

2-A

Pricing

Information

Number

of Firm Shares: 2,941,177

Number

of Option Shares: 441,176

Public

Offering Price per Share: $1.70

Underwriting

Discount per Share: $0.119 (7.0%)

Proceeds

to Company per Share (before expenses): $1.581

SCHEDULE

2-B

Written

Testing-the-Waters Communications and Confidential Marketing Materials

None.

SCHEDULE

2.10

Registration

Rights of Third Parties

None.

SCHEDULE

List

of Lock-Up Parties

Eric

Healy

John

Dalfonsi

Byron

Riché Jones

Greg

Somerville

Lindsey

L. Schwartz

B-1

EXHIBIT

Form

of Lock-Up Agreement

[See

attached]

B-2

EXHIBIT

Form

of Press Release

BranchOut

Food Inc.

[Date]

BranchOut

Food Inc. (the “Company”) announced today that Lake Street Capital Markets LLC, acting as representative for the underwriters

in the Company’s public offering of _______ shares of the Company’s common stock, is [waiving] [releasing] a lock-up restriction

with respect to _________ shares of the Company’s common stock held by [certain officers or directors] [an officer or director]

of the Company. The [waiver] [release] will take effect on _________, 20___, and the shares may be sold on or after such date.

This

press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or sale is

prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration

under the Securities Act of 1933, as amended.

C-1

EX-5.1

Filename: ex5-1.htm · Sequence: 3

Exhibit

5.1

October 26, 2026

BranchOut

Food Inc.

205 SE Davis Ave., Suite C

Bend,

Oregon 97702

O S A N G E L E S, C A

S A N F R A N C I S C O, C A

W I L M I N G T O N, D E

N E W Y O R K, N Y

H O U S T O N, T X

10100

SANTA MONICA BLVD.

13th FLOOR

LOS ANGELES

CALIFORNIA 90067

SAN

FRANCISCO

150 CALIFORNIA STREET

15th FLOOR

SAN FRANCISCO

CALIFORNIA 94111-4500

DELAWARE

919 NORTH MARKET STREET

17th FLOOR

P.O. BOX 8705

WILMINGTON

DELAWARE 19899-8705

NEW

YORK

1700 BROADWAY

36th FLOOR

NEW YORK

NEW YORK 10019

HOUSTON

440 LOUISIANA STREET

SUITE 900

HOUSTON

TEXAS 77002

Re:

Prospectus Supplement to Registration Statement on Form S-3 (Registration No. 333-287500)

Ladies

and Gentlemen:

have acted as counsel to BranchOut Food Inc., a Nevada corporation (the “Company”), in connection with (i) the preparation

and filing with the Securities and Exchange Commission (the “Commission”) of a Registration Statement on Form S-3 (Registration

No. 333-299400) which was declared effective by the Commission on October 16, 2026 (the “Registration Statement”) and the

prospectus therein (the “Base Prospectus”), relating to the offering from time to time, pursuant to Rule 415 of the General

Rules and Regulations of the Commission promulgated under the Securities Act of 1933, as amended (the “Securities Act”),

of securities of the Company with an aggregate offering price of up to $50,000,000; (ii) the Prospectus Supplement of the Base Prospectus,

dated October 23, 2026 (the “Prospectus Supplement”), filed with the Commission, relating to the issuance and sale by the

Company of 2,941,177 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common

Stock”) pursuant to that certain underwriting agreement (the “Underwriting Agreement”) to be entered into by and between

the Company and Lake Street Capital Markets LLC, acting as representative of the underwriters (the “Representative”); and

(iii) the current report on Form 8-K of the Company dated October 23, 2026 (the “Form 8-K”), pertaining to the Shares and

which will include this opinion letter as an exhibit and result in it being filed by the Company with the Commission as Exhibit 5.1 to

the Registration Statement by incorporation by reference.

connection with this opinion, we have examined instruments, documents, certificates and records which we have deemed relevant and necessary

for the basis of our opinion hereinafter expressed including (a) the Registration Statement, including the exhibits thereto, the Base

Prospectus, and the Prospectus Supplement, (b) the Company’s Articles of Incorporation, as amended to date, (c) the Company’s

Bylaws, (d) certain resolutions of the Board of Directors of the Company, (e) the Underwriting Agreement, and (f) such other documents,

corporate records, and instruments as we have deemed necessary for purposes of rendering the opinions set forth herein.

to certain factual matters, we have relied upon certificates of the officers of the Company and have not sought to independently verify

such matters. In such examination, we have assumed (a) the authenticity of original documents and the genuineness of all signatures,

including signatures made and/or transmitted using electronic signature technology (e.g., via DocuSign or similar electronic signature

technology); (b) the conformity to the originals of all documents submitted to us as copies; (c) the truth, accuracy, and completeness

of the information, representations and warranties contained in the records, documents, instruments and certificates we have reviewed;

(d) the legal capacity of all natural persons; (e) the Registration Statement, and any amendments (including post-effective amendments)

thereto, will remain effective at the time of issuance of any Shares thereunder; (f) the Company will issue and deliver the Shares in

the manner contemplated by the Registration Statement, the Base Prospectus, Prospectus Supplement and the Underwriting Agreement against

payment of valid consideration therefor; (g) the Shares will be issued and sold in compliance with applicable federal and state securities

laws; and (h) the obligations of parties to the Underwriting Agreement other than the Company are valid, binding and enforceable.

Page 2

Based

on the foregoing, and subject to the qualifications and limitations stated herein, it is our opinion that the Shares have been duly

authorized for issuance and, when issued, delivered and paid for in the manner described in the Registration Statement, the Base

Prospectus, the Prospectus Supplement and the Underwriting Agreement, the Shares will be validly issued, fully paid and nonassessable.

express no opinion as to the laws of any jurisdiction, other than the law of the State of New York and Chapter 78 of the Nevada Revised

Statutes.

hereby consent to the filing of this opinion with the Commission as Exhibit 5.1 to the Company’s Form 8-K and to the incorporation

by reference of this opinion in the Registration Statement, and to the reference to our firm under the caption “Legal Matters”

in the Prospectus Supplement. In giving this consent, we do not thereby admit that we are included in the category of persons whose

consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.

This

opinion is expressed as of the date hereof, and we disclaim any undertaking to advise you of any subsequent changes in the facts

stated or assumed herein or of any subsequent changes in applicable law.

Very

truly yours,

/s/

Pachulski Stang Ziehl & Jones LLP

Pachulski

Stang Ziehl & Jones LLP

EX-99.1

Filename: ex99-1.htm · Sequence: 4

Exhibit

99.1

BranchOut

Food Inc. Announces $5.0 Million Underwritten Public Offering

BEND,

Ore., October 23, 2026 /GlobeNewswire/ — BranchOut Food Inc. (Nasdaq: BOF) (“BranchOut” or the “Company”),

a growth-stage consumer packaged foods company focused on developing, manufacturing, marketing and distributing clean-label, plant-based

dried fruit and vegetable snacks, today announced the pricing of an underwritten public offering of 2,941,177 shares of its common stock

at a public offering price of $1.70 per share (the “Offering”). Gross proceeds to the Company, before deducting underwriting

discounts and commissions and estimated offering expenses, are expected to be approximately $5.0 million. All of the shares in the Offering

are to be sold by the Company.

Lake

Street Capital Markets, LLC is acting as the representative of the underwriters for the Offering. The Company has granted the representative

a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the Offering solely to cover over-allotments.

The

Offering is expected to close on or about October 26, 2026, subject to satisfaction of customary closing conditions.

The

Company intends to use the net proceeds from the Offering for working capital and general corporate purposes, including operating expenses

and capital expenditures.

The

shares of common stock are being offered pursuant to a registration statement on Form S-3 (File No. 333-299400), which was declared effective

by the Securities and Exchange Commission (the “SEC”) on October 16, 2026. The Offering is being made only by means of a

prospectus supplement and accompanying prospectus forming a part of the registration statement. A prospectus supplement relating to and

describing the terms of the Offering will be filed with the SEC and will be available free of charge on the SEC’s website at www.sec.gov.

Copies of the prospectus supplement and accompanying prospectus may also be obtained, when available, from Lake Street Capital Markets,

LLC, 121 South 8th Street, Suite 1000, Minneapolis, Minnesota 55402, by telephone at (612) 326-1305 or by email at capitalmarkets@lakestreetcm.com.

Disclaimer

This

press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale

of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration

or qualification under the securities laws of any such state or other jurisdiction.

About

BranchOut Food Inc.

BranchOut

Food Inc. (Nasdaq: BOF) is a leading international food technology company specializing in the production of high-quality dehydrated

fruit- and vegetable-based products through its proprietary GentleDry™ technology. This next-generation dehydration method is designed

to preserve the nutrition, quality and taste of fresh produce. BranchOut’s technology enables the Company to serve branded, ingredient

and private-label customers. For more information, visit www.branchoutfood.com or follow BranchOut Food on social media.

Forward-Looking

Statements

This

press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including

statements regarding the Offering, the expected grant and potential exercise of the over-allotment option, the Company’s expected

use of proceeds and the timing, size, terms and completion of the Offering. Forward-looking statements are generally identified by words

such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,”

“potential,” “should,” “will,” “would” and similar expressions. These forward-looking

statements are based on management’s current expectations and assumptions and are subject to risks and uncertainties that could

cause actual results to differ materially from those expressed or implied, including market conditions; the Company’s ability to

complete the Offering on acceptable terms or at all; volatility in the market price of the Company’s common stock; the satisfaction

of customary closing conditions; and the other risks and uncertainties described under “Risk Factors” in the prospectus supplement

relating to the Offering and in the Company’s filings with the SEC, including its most recent Annual Report on Form 10-K and subsequent

Quarterly Reports on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements. Except as required

by law, the Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances after

the date of this press release.

For

more information:

ir@branchoutfood.com

SOURCE

BranchOut Food Inc.

GRAPHIC

Filename: ex5-1_001.jpg · Sequence: 5

Binary file (21107 bytes)

Download ex5-1_001.jpg

GRAPHIC

Filename: ex99-1_001.jpg · Sequence: 6

Binary file (23067 bytes)

Download ex99-1_001.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 11

v3.26.3

Cover

Oct. 23, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Oct. 23, 2026

Entity File Number

001-41723

Entity Registrant Name

BRANCHOUT

FOOD INC.

Entity Central Index Key

0001962481

Entity Tax Identification Number

87-3980472

Entity Incorporation, State or Country Code

Entity Address, Address Line One

205

SE Davis Avenue

Entity Address, City or Town

Bend

Entity Address, State or Province

Entity Address, Postal Zip Code

97702

City Area Code

(844)

Local Phone Number

263-6637

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock, par value $0.001 per share

Trading Symbol

BOF

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration